<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5461351</article-id><article-id pub-id-type="doi">10.3389/fcimb.2017.00231</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>PKC-&#x003b7;-MARCKS Signaling Promotes Intracellular Survival of Unopsonized <italic>Burkholderia thailandensis</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Micheva-Viteva</surname><given-names>Sofiya N.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/415038/overview"/></contrib><contrib contrib-type="author"><name><surname>Shou</surname><given-names>Yulin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ganguly</surname><given-names>Kumkum</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/442541/overview"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Terry H.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/405853/overview"/></contrib><contrib contrib-type="author"><name><surname>Hong-Geller</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/46486/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Bioscience Division, Los Alamos National Laboratory</institution><country>Los Alamos, NM, United States</country></aff><aff id="aff2"><sup>2</sup><institution>Center for Infectious Disease and Immunity and Department of Internal Medicine, University of New Mexico Health Sciences Center</institution><country>Albuquerque, NM, United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Mary O'Riordan, University of Michigan, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: &#x000d6;zlem Yilmaz, Medical University of South Carolina, United States; Miguel A. Valvano, Queen's University Belfast, Ireland</p></fn><corresp id="fn001">*Correspondence: Elizabeth Hong-Geller <email xlink:type="simple">ehong@lanl.gov</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>231</elocation-id><history><date date-type="received"><day>11</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Micheva-Viteva, Shou, Ganguly, Wu and Hong-Geller.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Micheva-Viteva, Shou, Ganguly, Wu and Hong-Geller</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Pathogenic <italic>Burkholderia</italic> rely on host factors for efficient intracellular replication and are highly refractory to antibiotic treatment. To identify host genes that are required by <italic>Burkholderia</italic> spp. during infection, we performed a RNA interference (RNAi) screen of the human kinome and identified 35 host kinases that facilitated <italic>Burkholderia thailandensis</italic> intracellular survival in human monocytic THP-1 cells. We validated a selection of host kinases using imaging flow cytometry to assess efficiency of <italic>B. thailandensis</italic> survival in the host upon siRNA-mediated knockdown. We focused on the role of the novel protein kinase C isoform, PKC-&#x003b7;, in <italic>Burkholderia</italic> infection and characterized PKC-&#x003b7;/MARCKS signaling as a key event that promotes the survival of unopsonized <italic>B. thailandensis</italic> CDC2721121 within host cells. While infection of lung epithelial cells with unopsonized Gram-negative bacteria stimulated phosphorylation of Ser175/160 in the MARCKS effector domain, siRNA-mediated knockdown of PKC-&#x003b7; expression reduced the levels of phosphorylated MARCKS by &#x0003e;3-fold in response to infection with Bt CDC2721121. We compared the effect of the conventional PKC-&#x003b1; and novel PKC-&#x003b7; isoforms on the growth of <italic>B. thailandensis</italic> CDC2721121 within monocytic THP-1 cells and found that &#x02265;75% knock-down of PRKCH transcript levels reduced intracellular bacterial load 100% more efficiently when compared to growth in cells siRNA-depleted of the classical PKC-&#x003b1;, suggesting that the PKC-&#x003b7; isoform can specifically mediate <italic>Burkholderia</italic> intracellular survival. Based on imaging studies of intracellular <italic>B. thailandensis</italic>, we found that PKC-&#x003b7; function stimulates phagocytic pathways that promote <italic>B. thailandensis</italic> escape into the cytoplasm leading to activation of autophagosome flux. Identification of host kinases that are targeted by <italic>Burkholderia</italic> during infection provides valuable molecular insights in understanding <italic>Burkholderia</italic> pathogenesis, and ultimately, in designing effective host-targeted therapies against infectious disease caused by intracellular pathogens.</p></abstract><kwd-group><kwd><italic>Burkholderia</italic></kwd><kwd>infection</kwd><kwd>RNA interference</kwd><kwd>autophagy</kwd><kwd>intracellular bacteria</kwd><kwd>protein kinase C</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Defense Threat Reduction Agency<named-content content-type="fundref-id">10.13039/100000774</named-content></funding-source><award-id rid="cn001">CBS.MEDBIO.02.10.LA.016</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="1"/><equation-count count="0"/><ref-count count="70"/><page-count count="15"/><word-count count="10691"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Intracellular bacteria often defy the traditional pathogen-directed antimicrobial therapies through adaptation mechanisms that co-opt host cell processes in order to maximize infection efficiency. Pathogenic <italic>Burkholderia</italic> species, including <italic>B. pseudomallei</italic> and <italic>B. mallei</italic>, the causative agents of human melioidosis and equine glanders, respectively, are intracellular pathogens of particular concern, since infections are highly refractory to a broad spectrum of antibiotics and are associated with a mortality rate of ~50% even with antibiotic treatment (Moore et al., <xref rid="B44" ref-type="bibr">1999</xref>; Wiersinga et al., <xref rid="B66" ref-type="bibr">2006</xref>; Currie et al., <xref rid="B18" ref-type="bibr">2010</xref>; Schweizer, <xref rid="B55" ref-type="bibr">2012</xref>). <italic>Burkholderia</italic> spp. employ two types of secretion systems, Type III (T3SS) and Type VI (T6SS), consisting of multiple effector proteins that mediate host invasion and intracellular survival, thus enabling <italic>Burkholderia</italic> avoidance of the host immune responses, resistance to antibiotic treatment, and establishment of latent infections (Stevens et al., <xref rid="B59" ref-type="bibr">2003</xref>; Burtnick et al., <xref rid="B8" ref-type="bibr">2008</xref>, <xref rid="B9" ref-type="bibr">2009</xref>, <xref rid="B7" ref-type="bibr">2011</xref>; Muangsombut et al., <xref rid="B45" ref-type="bibr">2008</xref>; Gong et al., <xref rid="B26" ref-type="bibr">2011</xref>). Chronic infections caused by <italic>B. pseudomallei</italic> are a major challenge to achieving sterile immunity and a contributing factor to disease spread outside of the endemic zone, Southeast Asia and northern Australia (Limmathurotsakul et al., <xref rid="B37" ref-type="bibr">2016</xref>). Sporadic infections with <italic>B. pseudomallei</italic> have been recorded in East Africa, the Caribbean, Central and South America, the Middle East, North America and Western Europe, emphasizing the effect of globalization on emerging infectious diseases (Doker et al., <xref rid="B21" ref-type="bibr">2014</xref>; Benoit et al., <xref rid="B4" ref-type="bibr">2015</xref>; Currie, <xref rid="B17" ref-type="bibr">2015</xref>).</p><p>In pursuit of effective treatment of persistent <italic>Burkholderia</italic> infections, several host transcriptomics studies have been performed to characterize changes in host gene expression in response to <italic>Burkholderia</italic> infection (Ulett et al., <xref rid="B62" ref-type="bibr">2005</xref>; Chin et al., <xref rid="B13" ref-type="bibr">2010</xref>; Mariappan et al., <xref rid="B38" ref-type="bibr">2013</xref>). Host genes that function in apoptosis, immune response, stress response, and cellular metabolism were found to be differentially regulated upon infection. Yeast two-hybrid screens of whole human and murine proteome libraries have identified 600 human and 846 murine protein interactions with <italic>B. mallei</italic> virulence factors, demonstrating high representation of host proteins that function in ubiquitination, phagosome formation, and actin cytoskeleton dynamics (Memisevic et al., <xref rid="B40" ref-type="bibr">2013</xref>, <xref rid="B41" ref-type="bibr">2015</xref>). To further characterize host gene function in response to <italic>Burkholderia</italic> infection, we performed a RNA interference (RNAi) screen of the human kinome to identify host factors that facilitate intracellular survival of <italic>Burkholderia thailandensis</italic>, a surrogate for the more virulent <italic>B. pseudomallei</italic>. Although ~1,000-fold less lethal than <italic>B. pseudomallei</italic> in animal models, <italic>B. thailandensis</italic> nevertheless induces phagocytic mechanisms and exhibits growth kinetics in primary human monocyte-derived dendritic cells similar to <italic>B. pseudomallei</italic> (Wiersinga et al., <xref rid="B66" ref-type="bibr">2006</xref>; Haraga et al., <xref rid="B28" ref-type="bibr">2008</xref>; Charoensap et al., <xref rid="B12" ref-type="bibr">2009</xref>). To validate the results of our RNAi screen, we used the clinical isolate <italic>B. thailandensis</italic> CDC2721121 previously shown to exhibit phenotypes that resemble pathogenic <italic>Burkholderia</italic> in cell culture studies (Glass et al., <xref rid="B25" ref-type="bibr">2006</xref>). <italic>Bt</italic> CDC2721121 has acquired the capsular polysaccharide virulence cluster, and thus exhibits <italic>B. pseudomallei</italic>-like phenotypes, including colony wrinkling, resistance to human complement binding, and survival within macrophages (Sim et al., <xref rid="B56" ref-type="bibr">2010</xref>).</p><p>Our RNAi screen revealed divergent roles for protein kinase C (PKC) isoform functions in promoting intracellular proliferation of <italic>B. thailandensis</italic>. The PKC family comprises at least 10 related lipid-sensitive serine/threonine kinases subdivided into three classes with particular features: (1) the classic PKCs (PKC&#x003b1;, PKC&#x003b2;I, PKC&#x003b2;II, PKC&#x003b3;), which are Ca<sup>2+</sup>-dependent and activated by both PS and DAG; (2) the novel PKCs (PKC&#x003b4;, PKC&#x003b5;, PKC&#x003b7;, PKC&#x003bc;, PKC&#x003b8;), which require DAG but not Ca<sup>2+</sup>; and (3) atypical PKCs (PKC&#x003b6;, PKC&#x003af;/&#x003bb;), which are Ca<sup>2+</sup>- and DAG-independent (Mochly-Rosen et al., <xref rid="B43" ref-type="bibr">2012</xref>). Classical Ca<sup>2+</sup>-dependent PKC isoforms are known to be key regulators of host innate immunity and phagocytosis of opsonized antigen through the IgG receptors (Breton and Descoteaux, <xref rid="B5" ref-type="bibr">2000</xref>; Underhill and Ozinsky, <xref rid="B64" ref-type="bibr">2002</xref>). In our assay we have used unopsonized <italic>B. thailandensis</italic> as a model of early infection event to study the effect of cellular innate immune responses in the restriction of intracellular bacterial growth. We identified the novel PKC-eta isoform, PKC&#x003b7;, as a host factor required for the successful growth of unopsonized <italic>B. thailandensis</italic> within professional phagocytes and epithelial cells. Other RNAi-based screens have previously discovered various novel PKC isoforms to be required for the colonization of epithelial tissue cells by intracellular pathogenic bacteria (Prudencio et al., <xref rid="B51" ref-type="bibr">2008</xref>; Jiwani et al., <xref rid="B30" ref-type="bibr">2012</xref>). Similarly, these discovery platforms were infected with unopsonized bacteria. We further characterized PKC-&#x003b7;/MARCKS signaling as a key event that promotes uptake of unopsonized <italic>B. thailandensis</italic> by host cells and demonstrated that opsonization is a key factor that determines receptor usage, triggers differential PKC signaling pathways, and eventually determines intracellular pathogen survival.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and methods</title><sec><title>Bacterial strains and growth conditions</title><p>The following bacterial strains were used in this study: (1) <italic>B. thailandensis</italic> DW503, a derivative from the environmental <italic>B. thailandensis</italic> E264 (gift from Dr. Mary Burtnick, University of South Alabama) (Burtnick et al., <xref rid="B6" ref-type="bibr">2001</xref>); (2) <italic>B. thailandensis</italic> CDC2721121, a clinical isolate obtained from the CDC (Glass et al., <xref rid="B25" ref-type="bibr">2006</xref>); and (3) <italic>Yersinia enterocolitica</italic> WA (pYV<sup>+</sup>, ATCC 27729). Both <italic>Burkholderia</italic> strains were grown on LB agar plates at 37&#x000b0;C and stored at 4&#x000b0;C for up to a week or were cultured on LB broth with aeration at 37&#x000b0;C prior to the infection of host cells. The <italic>B. thailandensis</italic> DW503-GFP strain was generated by introduction of the BHR4-GFP plasmid (gift from Dr. M. Burtnick) into bacterial cells via electroporation and selection of clones using LB agar plates containing 50 &#x003bc;g/ml gentamicin. For cell infection experiments, <italic>Y. enterocolitica</italic> WA was grown at 26&#x000b0;C in brain heart infusion (BHI, Difco, Detroit, Mich) broth for 18 h in an orbital shaker at 180 rpm, followed by dilution of the bacterial culture to obtain 0.1 OD<sub>660</sub> and additional growth for 2 h at 37&#x000b0;C (100 rpm) to stimulate production of the T3SS.</p></sec><sec><title>Tissue culture cell growth conditions</title><p>THP-1 human monocytes (ATCC TIB-202) were maintained in RPMI-1640 GlutaMax media (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (HyClone, Logan, UT). A549 cells (ATCC CCL-185) were cultured in DMEM high glucose medium containing 10% FBS (Invitrogen) at 37&#x000b0;C and 5% CO<sub>2</sub>. The RFP-LC3B stable cell line was generated by transfection of A549 cells with pmRFP-LC3 (Addgene plasmid #21075) (Kimura et al., <xref rid="B32" ref-type="bibr">2007</xref>) and flow cytometry sorting using the BD FACSAria. Phorbol 12-myristate 13-acetate (PMA) and mannan from <italic>S. cerevisiae</italic> were obtained from Sigma-Aldrich (St. Louis, MO).</p></sec><sec><title>Validation screen using imaging flow cytometry</title><p>We validated host gene function in intracellular bacterial replication using a differential two-step labeling method to distinguish between intracellular and extracellular <italic>B. thailandensis</italic>. <italic>Bt</italic> CDC2721121 cells (10<sup>8</sup>) were incubated in 1 ml PBS (pH6) containing 1 &#x003bc;g/ml FITC (green) for 15 min at room temperature, washed four times in 1 ml PBS, and resuspended in LB. THP-1 cells were treated with siRNAs as described for the screen and infected with FITC-labeled <italic>Bt</italic> CDC2721121 at MOI 10, 72 h post-siRNA treatment. Growth of extracellular bacteria was suppressed by adding kanamycin (250 &#x003bc;g/ml) 2 h post-infection. After another 3 h, the infected THP-1 cells were pelleted at 800 g for 2 min and resuspended in fresh antibiotic-free RPMI/10% FBS. THP-1 cells were collected 24 h post-infection, fixed for 20 min in 1% paraformaldehyde, and incubated for 1 h in blocking buffer containing 10% sheep serum and 1% bovine serum albumin (BSA). Rabbit anti-<italic>B. thailandensis</italic> serum (gift of Dr. Paul Brett, University of South Alabama) was then added (1:500 dilution) to the blocking buffer, and cells were incubated for an additional 1 h. Following three rounds of washing in PBS, THP-1 cells were incubated for 30 min in PBS containing 1% BSA and PE (red)-conjugated anti-rabbit goat IgG (1:1,000 dilution). Thus, extracellular adherent <italic>Burkholderia</italic> were double-labeled with FITC and PE fluorescence, whereas intracellular bacteria were single-labeled with FITC. The labeled THP-1 cells were analyzed using imaging flow cytometry (Amnis ImageStream<sup>X</sup>) with the following data collection parameters: slow flow rate, 60 &#x000d7; magnification, and extended depth of field. Images were collected from the darkfield, brightfield, FL1 (488ex/560em nm), and FL2 (488ex/595em nm) channels. Uninfected THP-1 cells treated with rabbit anti-<italic>B. thailandensis</italic> sera and PE-conjugated anti-rabbit IgG treatment, and <italic>Bt</italic> CDC2721121-FITC infected THP-1 cells not treated with PE-conjugated anti-rabbit IgG, served as single color controls to establish compensation that excluded channel cross-talk. The IDEAS 5.0 software was used to define the localization of internalized bacteria and to determine the percentage of single vs. double-labeled THP-1 cells.</p></sec><sec><title>Western blot analysis</title><p>THP-1 cells treated with 50 nM siRNA were washed twice with chilled PBS and lysed on ice for 45 min with RIPA Lysis and Extraction Buffer (Thermo Scientific, Grand Island, NY) supplemented with a cocktail of protease and phosphatase inhibitor mixture (Thermo Scientific). Lysates were centrifuged (12000 rpm, 15 min), supernatants were collected, and total protein was quantified with the BCA kit (Pierce). Equal amounts of protein (10 &#x003bc;g) were run on SDS&#x02013;PAGE and transferred to PVDF membranes (Millipore, Billerica, MA) blocked with 5% nonfat dried milk in TBST (25 mM Tris [pH 7.6], 137 mM NaCl, and 0.2% Tween 20). Membranes were incubated with primary antibodies to PKC-&#x003b1; (sc-8393, H-7), PKC-&#x003b7; (sc-215, C-15), and actin (sc-58673, 2Q1055) (Santa Cruz Biotechnology, Santa Cruz, CA) at 4&#x000b0;C overnight, washed with TBST, and incubated with HRP-conjugated secondary antibody. Immunoreactive proteins were visualized with luminol reagent (Santa Cruz Biotechnology).</p></sec><sec><title>Cytotoxicity assays</title><p>The CytoTox-ONE&#x02122; Assay (Promega, Madison, WI) was used to measure the release of lactate dehydrogenase (LDH) from cells with a damaged membrane. Normalized LDH activity was calculated by subtracting the fluorescent readings in the supernatants of untreated control cells from the experimental sample readings. The percentage of necrotic cells was determined as the fluorescence signal measured in the experimental sample relative to the signal obtained from a control sample treated with 0.1% Triton and processed in parallel. The results were analyzed using the Synergy2 Multi-Mode Microplate Reader (BioTec, Winooski, VT) at 560 nm excitation and 590 nm emission.</p></sec><sec><title>ELISA to determine levels of phosphorylated marcks protein</title><p>A549 cells (2 &#x000d7; 10<sup>5</sup>) were washed twice in ice-cold PBS and resuspended in 250 &#x003bc;l ice-cold Cell Lysis Buffer (Cell Signaling Technology, Danvers, MA) supplemented with 1 mM PMSF and 1X Halt Protease Inhibitor cocktail (ThermoScientific). Whole cell lysates were subjected to centrifugation at 12,000 g for 10 min at 4&#x000b0;C, and the resulting supernatants were analyzed using the PathScan Phospho-MARCKS (Ser152/156) Sandwich ELISA Kit (Cell Signaling Technology) following the manufacturer's instructions. Whole cell lysates (in triplicate) were incubated with pMARCKS antibody-coated microwells overnight at 4&#x000b0;C.</p></sec><sec><title><italic>B. thailandensis</italic> intracellular survival</title><p>Overnight cultures of A549 cells were infected with <italic>B. thailandensis</italic> CDC2721121 at the indicated MOI for 2 h at 37&#x000b0;C. Cells were washed with PBS and resuspended in DMEM containing 250 &#x003bc;g/ml kanamycin to suppress the growth of extracellular bacteria. After 3 h of antibiotic exposure, cells were washed 3 &#x000d7; with PBS and further cultured in antibiotic-free DMEM. Prior to analysis, cells were washed with warm PBS and lysed in 0.1% Triton X-100 in PBS for 5 min. The lysis mixture was diluted, plated on LB agar plates, incubated overnight at 37&#x000b0;C for growth, and then quantified by colony counts. The replication index was calculated as the fold increase of intracellular bacteria between two time points.</p></sec><sec><title>Analysis of multinucleated giant cell (MNGC) formation</title><p>A549 cells infected with <italic>Bt</italic> CDC2721121 in 6-well plates were washed with PBS and treated with acid ethanol [5% acetic acid (v/v), 5% dH2O and 90% ethanol (v/v)] for 30 min at room temperature. Cells were washed twice with PBS and stained with Giemsa solution (0.1% w/v) for 30 s at room temperature. After washing with dH2O, cells were air-dried and analyzed using a light microscope. At least 10 fields per view at 10 &#x000d7; magnification were analyzed to obtain the percentage of MNGCs, where a cell was considered a MNGC if cell fusions with 3 or more nuclei were present.</p></sec><sec><title>Gene expression</title><p>Total RNA from <italic>Burkholderia</italic> was isolated using the RNeasy Miniprep Kit (Qiagen, Germantown, MD) and subjected to the TURBO DNA-free Kit (Life Technologies, Grand Island, NY) for DNase treatment and removal. 100 ng purified RNA was used for quantitative real-time PCR with the TaqMan RNA-to-C<sub><italic>T</italic></sub> 1-Step kit following the manufacturer's instructions (Life Technologies). Transcripts were normalized to 18S ribosomal RNA levels, using the VIC-MGB primer limited set, and calculated relative to the control sample using the <inline-formula><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mo>&#x00394;</mml:mo><mml:mo>&#x00394;</mml:mo><mml:mtext>C</mml:mtext></mml:mrow></mml:msubsup></mml:math></inline-formula> method.</p></sec><sec><title>Imaging flow cytometry to quantify autophagosomes and cytoplasmic <italic>B. thailandensis</italic></title><p>A549 cells expressing RFP-LC3B were grown on Corning-Costar 96-well plates with coverslip bottoms and treated with 10 &#x003bc;M rapamycin or infected with <italic>Bt</italic> CDC2721121 at MOI 10. Cells were fixed with 4% paraformaldehyde 5 h post-treatment, washed with PBS, and stored in ProLong Gold mount with DAPI nuclear stain (LifeTechnologies). Samples were acquired at optimized laser strength (100 mW for 488) with an area classifier (number of pixels in &#x003bc;m2) set at 50 using a Zeiss inverted fluorescence microscope. Images were acquired for each cell at 60 &#x000d7; magnification and enhanced depth of perception. ~2,000 cells were analyzed for each experimental or isotype control sample, and 500 cells were acquired for each single positive compensation control sample. The integrated software INSPIRE (version 6.0.154, Amnis) was used for data collection. Gating was determined for each experimental sample and cut-offs were defined using an untreated A549-RFP-LC3 control sample. All single and focused cells used in our analysis had zero saturated pixels. LC3 positive spots were identified by creating a spot mask for peak intensities that were greater than background. The peak to background ratio was determined for each experiment based on untreated controls. This spot mask was then converted into a spot count feature. The bacteria and LC3 spot counts were plotted against a normalized frequency of cells to generate histograms. To determine the bacterial counts in the cytoplasm that were not associated with LC3-positive spots, we used the following algorithm: Spot {Intensity (MO2, Ch02, 114-4095), Ch02 Bright, 16.25, 1}, and Not Spot {Intensity (M04,ch04, 240-4095), Ch04, Bright, 4, 1}. Analysis was performed on the compensated image files using algorithms in IDEAS (version 5.0, Amnis) image analysis software.</p></sec><sec><title>Statistical analysis</title><p>One-way ANOVA and <italic>Z</italic>-test were used to evaluate the significance of responses in the HTS experiments. For samples <italic>n</italic> &#x02265; 3, the statistical significance of the difference between experimental and control data sets was determined via Student's <italic>t</italic>-test and the normal distributions for multiple-comparisons of experimental samples were confirmed using the Tukey-Kramer test where we specified that the entire set of comparisons should have a family error rate of 0.05.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>RNAi-based gene silencing screen of host kinases in host-<italic>B. thailandensis</italic> interactions</title><p>We performed a functional genomic screen using a siRNA library against 718 annotated human kinases or kinase-interacting proteins to identify host proteins required for <italic>B. thailandensis</italic> survival in human monocytic THP-1 cells (Supplementary Materials and Methods and Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>). We identified 35 initial hits (Table <xref ref-type="table" rid="T1">1</xref>), in which siRNA-mediated gene silencing resulted in &#x02265;50% reduction in host cell-associated bacteria. Genes encoding kinases that play a role in host cell survival pathways were highly represented in our screen. Screen hits also included kinases that regulate cell adhesion and actin dynamics, cell processes that are essential for phagocytosis of intracellular bacteria (Kuijl et al., <xref rid="B33" ref-type="bibr">2007</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Host genes required for intracellular <italic>B. thailandensis</italic> proliferation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Gene name</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Accession no</bold>.</th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Biochemical activity</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Biological function</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">ABL1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_005157">NM_005157</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Protein tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell division differentiation, adhesion, and stress</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AKT1/PKB</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_005163">NM_005163</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine-protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell survival, growth, proliferation, motility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AKT2/PKBB</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_005163">NM_005163</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine-protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell survival, insulin signaling, motility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AURKA</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_198437">NM_198437</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Cell cycle-regulated serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Organizing microtubules during cell division</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AURKC</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_198437">NM_198437</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine/tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Mitosis and meiosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CALM1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006888">NM_006888</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Calcium binding phosphorylase kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Centrosome cycle, cytokinesis, cell signaling</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAMK1G</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_020439">NM_020439</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Ca<sup>++</sup>/calmodulin-dependent kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Ca<sup>++</sup>-triggered signaling cascade</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAMK2A</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_015981">NM_015981</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Gene transcription, cell survival, apoptosis, cytoskeleton</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAMK2B</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_172084">NM_172084</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Same as CAMK2A</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAMKK2</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_172215">NM_172215</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Ca<sup>++</sup>/calmodulin-dependent serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Gene transcription, cell survival, cytoskeleton reorganization</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">EPHA3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_182644">NM_182644</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Receptor protein-tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, development, migration</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">EPHB2</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_004443">NM_004443</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Receptor protein-tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, development, migration, and adhesion</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ERBB3/ cErbB3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001005915">NM_001005915</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Receptor tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Gene expression, cytoskeletal rearrangement, cell survival</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HK1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_000188">NM_000188</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Produce glucose-6-phosphate</td><td valign="top" align="left" rowspan="1" colspan="1">Glycolysis, energy generation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HK2</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_000189">NM_000189</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Produce glucose-6-phosphate</td><td valign="top" align="left" rowspan="1" colspan="1">Glycolysis, energy generation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HK3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002115">NM_002115</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Produce glucose-6-phosphate</td><td valign="top" align="left" rowspan="1" colspan="1">Glycolysis, energy generation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">INSRR</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_014215">NM_014215</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Transmembrane receptor protein tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, apoptosis, pH sensor</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ITPKA/IP3KA</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002220">NM_002220</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Phosphorylation of inositol 1,4,5-trisphosphate to Ins (1,3,4,5) P4</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, motility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KDR</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002253">NM_002253</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Receptor protein-tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Proliferation, survival, migration</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MAST3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_015016">NM_015016</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Mitosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PAK3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002578">NM_002578</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine p21-activating kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell cycle, migration</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PIK3R1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_181523">NM_181523</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Phosphorylation of the inositol ring of PI at the 3&#x02032; position</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, vesicular trafficking, migration, insulin metabolism</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PIK3R5/P101-PI3K</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_14308">NM_14308</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Phosphorylation of the 3'OH of the inositol ring of phosphoinositide (PI)</td><td valign="top" align="left" rowspan="1" colspan="1">Cell growth, proliferation, differentiation, motility, and intracellular trafficking</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PIP5KIA</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_003557">NM_003557</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Phosphorylation of 4-phosphate of PI</td><td valign="top" align="left" rowspan="1" colspan="1">Endocytosis and cell migration</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PIP5K2B</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_003559">NM_003559</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Phosphorylation of 5&#x02032;-phosphate of PI at the 4&#x02032;OH</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, proliferation, motility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PKN3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_013355">NM_013355</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine-protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell growth, migration, adherence</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PRKCH</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006255">NM_006255</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine-protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell signaling, proliferation, survival, motility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PTK7</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_152881">NM_152881</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Transduction of extracellular signals across the cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Wnt cell signaling, polarity, adhesion</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PRKACB/PKA C-&#x003b2;</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002731">NM_002731</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">cAMP-dependent catalytic subunit of serine/threonine-protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Regulation of lipid and glucose metabolism, cell signaling</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCK1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002591">NM_002591</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Catalyzes the formation of phosphoenolpyruvate from oxaloacetate</td><td valign="top" align="left" rowspan="1" colspan="1">Regulation of gluconeogenesis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STK11/LKB1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_000455">NM_000455</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine kinase, phosphorylates AMPK</td><td valign="top" align="left" rowspan="1" colspan="1">Cell polarity and survival, metabolic reprogramming</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STK35/CLIK1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_080836">NM_080836</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell cycle, migration</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STK38L/NDR1</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_015000">NM_015000</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Mg<sup>++</sup> binding serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cytoskeletal reorganization, cell invasion</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STK4</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006282">NM_006282</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">apoptosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TYRO3</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006293">NM_006293</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">Receptor protein-tyrosine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">Cell survival, proliferation and regulation</td></tr></tbody></table></table-wrap><p>For subsequent validation studies, we used the clinical isolate <italic>B. thailandensis</italic> CDC2721121. We applied differential fluorescent labeling of extracellular and intracellular <italic>Bt</italic> CDC2721121 to assess the efficiency of pathogen internalization and survival within THP-1 cells using imaging flow cytometry (Figure <xref ref-type="fig" rid="F1">1A</xref>). We observed that siRNA-mediated silencing of six genes regulating actin dynamics (PTK7, EPHB2, and PRKCH), calcium signaling (CALM1), cell adhesion (STK35), and cell proliferation (STK38L) resulted in a significant (z&#x0003e;-2) reduction of <italic>B. thailandensis</italic> intracellular load in THP-1 cells, compared to cells treated with control siRNA (Figure <xref ref-type="fig" rid="F1">1B</xref>, Supplementary Table <xref ref-type="supplementary-material" rid="SM1">2</xref>). The RNAi silencing of target gene activity in monocytic THP-1 cells was efficient (&#x0003e;75%), transcript-specific (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1</xref>), and did not affect host cell viability when compared to the control cells treated with non-targeting siRNA (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">2</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Differential fluorescent labeling of intracellular <italic>B. thailandensis</italic> upon siRNA knockdown of selected host kinase genes. <bold>(A)</bold> THP-1 cells pretreated with 50 nM siRNA for 72 h were infected with FITC-labeled <italic>Bt</italic> CDC2721121 for 2 h at MOI 10. Kanamycin (250 &#x003bc;g/ml) was then added for 3 h to suppress extracellular bacterial growth, after which the infected cells were cultured in antibiotic-free media for 20 h. Bacterial cells remaining extracellular were double-labeled with FITC and <italic>B. thailandensis</italic> rabbit antiserum/PE-conjugated anti-rabbit IgG, whereas intracellular bacteria were single-labeled with only FITC. Imaging flow cytometry analysis of infected THP-1 cells was performed using the Amnis ImageStream<sup>X</sup>, and the frequencies of singly and double labeled bacteria were determined using the IDEAS 5.0 software. FITC, fluorescein isothiocyanate (ex495 nm/em519 nm); PE, Phycoerythrin (ex 488 nm/em575 nm). <bold>(B)</bold> The ratio of extracellular vs. intracellular bacteria in THP-1 cells siRNA-depleted of target kinases was used to evaluate kinase function in intracellular <italic>B. thailandensis</italic> proliferation. The average and standard deviation were determined from three independent experiments (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">2</xref>). The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for the ratio of extracellular to intracellular pathogen in cells siRNA-depleted of target gene compared to cells treated with control siRNA.</p></caption><graphic xlink:href="fcimb-07-00231-g0001"/></fig></sec><sec><title>Differential role of conventional and novel PKC isoforms in <italic>B. thailandensis</italic> survival in human monocytes</title><p>We focused our study on PRKCH, which encodes for PKC-&#x003b7;, a novel protein kinase C isoform that requires diacylglycerol (DAG), but not Ca<sup>2+</sup>, for activation. Interestingly, we did not recover any classical Ca<sup>2+</sup>-dependent PKC isoforms (&#x003b1;, &#x003b2;, and &#x003b3;), which are known to be key regulators of opsonized antigen phagocytosis (Underhill and Ozinsky, <xref rid="B64" ref-type="bibr">2002</xref>). To further examine the differential functions of conventional and novel PKC isoforms in <italic>B. thailandensis</italic> CDC2721121 survival within host cells, we compared the intracellular bacterial load in THP-1 cells siRNA-depleted of PKC-&#x003b7; or PKC-&#x003b1;. Upon downregulation of PKC-&#x003b7;, the average number of intracellular <italic>B. thailandensis</italic> per THP-1 cell dropped by &#x0003e;4-fold compared to control (CTL) cells (Figure <xref ref-type="fig" rid="F2">2A</xref>). In comparison, downregulation of PKC-&#x003b1; resulted in decreased intracellular bacterial count per host cell by &#x0003c; 2-fold. By Western blot, we observed that siRNA directed toward the PRKCH transcripts was specific, causing the depletion of PKC-&#x003b7;, but not PKC-&#x003b1; protein (Figure <xref ref-type="fig" rid="F2">2B</xref>). To further test PKC isoform specificity, we examined the induction of host cell death by <italic>B. thailandensis</italic> CDC2721121 infection in lung epithelial A549 cells. This cell model has been previously used to examine <italic>Burkholderia</italic> replication in non-phagocytic cells via formation of polymorphonuclear cells (Wongprompitak et al., <xref rid="B68" ref-type="bibr">2009</xref>; Kunyanee et al., <xref rid="B34" ref-type="bibr">2016</xref>). We transiently expressed dominant-negative mutants of PKC-&#x003b7; (PKC-&#x003b7;-DN) and PKC-&#x003b1; (PKC-&#x003b1;-DN), and a constitutively-active PKC-&#x003b7; (PKC-&#x003b7;-CAT), which lacks the N-terminal regulatory domain, in A549 cells (Soh and Weinstein, <xref rid="B58" ref-type="bibr">2003</xref>). Despite the great data variability originating from transient transfection experiments we observed that cells expressing PKC-&#x003b7;-DN demonstrated reduced host cell death by ~3-fold in response to <italic>Bt</italic> CDC2721121 infection, whereas expression of PKC-&#x003b1;-DN had no significant effect, compared to A549 cells carrying empty vector (CTL) or PKC-&#x003b7;-CAT (Figure <xref ref-type="fig" rid="F2">2C</xref>). These results indicate that the novel PKC-&#x003b7; isoform plays a more significant role in <italic>B. thailandensis</italic> intracellular survival and induction of host cell death, compared to the conventional PKC-&#x003b1; isoform.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>PKC-&#x003b7; plays bigger role than PKC-&#x003b1; in unopsonized <italic>B. thailandensis</italic> intracellular survival and induction of host cell death. <bold>(A)</bold> Quantitative analysis of internalized <italic>Bt</italic> CDC2721121 was determined by plotting bacteria spot counts, 1&#x02013;2 &#x003bc;m fluorescent puncti corresponding to bacteria size and fluorescent marker, against a normalized frequency, percentage of analyzed cells selected from the total number of single and focused cells. Bacterial counts in the cytoplasm that were singly labeled with FITC and not associated with the PE-labeled extracellular bacterial spots were calculated as described in the Materials and Methods. R, the gate excluding the cells exhibiting background fluorescence from the analysis, shows the mean value of fluorescence (MF) spots associated with intracellular bacteria per single host cell. R and NF (Normalized frequency) were determined by selective analysis of at least 5000 single and focused cells per sample using the IDEAS 5.0 software. A representative result of one out of 3 independent experiments is shown. <bold>(B)</bold> THP-1 cells were transfected with 50 nM siRNA against PRKCH or non-targeting control (CTL) siRNA and collected 72 h post treatment. Whole cell lysates were analyzed by Western blot using antibodies against PKC-&#x003b7;, PKC-&#x003b1;, and actin. <bold>(C)</bold> A549 cells transiently expressing PKC-&#x003b7;-DN, PKC-&#x003b1;-DN, and PKC-&#x003b7;-CAT, were infected with <italic>Bt</italic> CDC2721121 at MOI 50 for 1 h, treated with kanamycin (250 &#x003bc;g/ml) for 3 additional hours to suppress extracellular bacterial growth, after which the infected cells were cultured in antibiotic-free media. At 40 h post-infection, the percentage of dead A549 cells was calculated as a ratio of LDH activity in the conditioned media relative to total enzyme activity in the infected cells lysed with 0.1% Triton. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for % cell death in transfected samples compared to infected cells transfected with an empty vector (CTL) for each experimental condition.</p></caption><graphic xlink:href="fcimb-07-00231-g0002"/></fig></sec><sec><title>Intracellular survival of <italic>B. thailandensis</italic> is dependent on MARCKS phosphorylation by PKC-&#x003b7;</title><p>The respiratory epithelium and nasal-associated lymphoid tissue serve as primary entry points for inhalational melioidosis (Owen et al., <xref rid="B49" ref-type="bibr">2009</xref>). <italic>Burkholderia</italic> invades host cells via phagocytosis, escapes the membrane-bound phagosome, and disseminates in the host cytoplasm to maintain an intracellular niche (Jones et al., <xref rid="B31" ref-type="bibr">1996</xref>). We investigated a potential role for PKC-&#x003b7; function in the activation of a downstream effector protein, MARCKS, upon <italic>Burkholderia thailandensis</italic> phagocytosis. MARCKS, an ~87 kD protein, functions as an actin cross-linking protein and a signal transducer in PKC-dependent pathways. MARCKS is activated by PKC-catalyzed phosphorylation of a conserved 25 aa basic effector domain (ED). Although MARCKS phosphorylation by the conventional PKC-&#x003b1; has been previously found to facilitate zymosan adherence to macrophage cells and promote phagocytosis (Allen and Aderem, <xref rid="B2" ref-type="bibr">1995b</xref>), the role of novel PKC isoforms on MARCKS function in response to bacterial infection has not yet been investigated.</p><p>We detected a ~2&#x02013;3-fold increase in phosphorylated MARCKS (pMARCKS) protein levels when normalized to total MARCKS protein in A549 cells infected with <italic>Bt</italic> CDC2721121 for 30, 60, or 180 min, compared to pMARCKS in uninfected cells, using an ELISA specific for MARCKS phosphorylation at Ser175/160 of the ED (Figure <xref ref-type="fig" rid="F3">3A</xref>). Interestingly, we also observed a time-dependent response to infection with a different Gram-negative pathogen, <italic>Yersinia entercolitica</italic>, in which pMARCKS levels increased from ~1.5-fold at 30 min post-infection to ~5-fold at 60 min, but decreased to basal levels at 180 min. This finding is consistent with the known virulence mechanisms of pathogenic <italic>Yersinia</italic> spp. employing a T3SS to inject Yop effector proteins into the host cells within180 min of infection to inhibit actin polymerization and the host phagocytic response (Zauberman et al., <xref rid="B70" ref-type="bibr">2006</xref>). In comparison, the potent PKC stimulator PMA induced a ~15-fold increase in pMARCKS levels after 30 min and an ~8-fold increase after 60 and 180 min. We also observed that siRNA-mediated knockdown of either MARCKS or PKC-&#x003b7; expression in A549 cells reduced pMARCKS levels by &#x0003e;3-fold in response to 30 or 60 min of infection with <italic>Bt</italic> CDC2721121, compared to host cells treated with non-targeting siRNA (siR-CTL) (Figure <xref ref-type="fig" rid="F3">3B</xref>). These data indicate that PKC-&#x003b7; participates in MARCKS ED phosphorylation upon infection of lung epithelial cells with Gram-negative bacteria.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>PKC-&#x003b7; is involved in host MARCKS phosphorylation upon bacterial infection (A) A549 cells were infected with <italic>Bt</italic> CDC2721121 at MOI 50 or <italic>Y. enterocolitica</italic> WA at MOI 20. After the indicated times, cells were lysed and levels of phosphorylated Ser152/156 in the MARCKS effector domain (pMARCKS) were quantified using the PathScan ELISA kit and compared to uninfected A549 cells. Cells were also treated with 100 nM PMA as a positive control. In all samples, pMARCKS levels were normalized to the total MARCKS protein levels. The average and standard deviation from three independent experiments are shown. <bold>(B)</bold> A549 cells were treated with 25 nM siRNA against MARCKS, PKC-&#x003b7;, or non-targeting control (CTL) for 72 h prior to infection with <italic>Bt</italic> CDC2721121. At the indicated time, cells were lysed and the levels of pMARCKS were quantified as fold change relative to uninfected A549 cells. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for fold pMARCKS change in samples treated with siRNA to MARCKS or PKC-&#x003b7;, compared to non-targeting siRNA samples (siR-CTL).</p></caption><graphic xlink:href="fcimb-07-00231-g0003"/></fig><p>To further link PKC-&#x003b7; and MARCKS function to bacterial survival within host cells, we demonstrated that PKC-&#x003b7; or MARCKS depletion via siRNA resulted in a ~10-fold and ~2.5-fold reduction, respectively, in the number of viable intracellular <italic>B. thailandensis</italic> in A549 cells following infection for 24 h, compared to cells treated with non-targeting siRNA (siR-CTL) (Figure <xref ref-type="fig" rid="F4">4A</xref>, light gray bars). This decrease in intracellular <italic>Burkholderia</italic> counts correlated with increased A549 viability of PKC-&#x003b7;&#x02013; or MARCKS-depleted cells, as measured by a ~2-fold reduction in LDH release (Figure <xref ref-type="fig" rid="F4">4A</xref>, dark gray bars). We also examined multi-nucleated giant cell (MNGC) formation as a result of <italic>Burkholderia</italic>-induced host cell fusion (Suparak et al., <xref rid="B61" ref-type="bibr">2005</xref>; Galyov et al., <xref rid="B22" ref-type="bibr">2010</xref>). Reduction of gene expression via MARCKS transcript-specific siRNA resulted in ~2-fold less MNGC counts as compared to A549 cells treated with non-targeting siRNA (siR-CTL) (Figure <xref ref-type="fig" rid="F4">4B</xref>). A statistically marginal difference between controls and experimental samples was observed in most assays where the MARCKS transcript levels were reduced via RNAi. There could be two logical explanations for this phenomenon, (i) native MARCKS transcript levels increase upon bacterial infection (see <bold>Figure 6B</bold>) counteracting the effect of the siRNA on MARCKS transcripts and (ii) MARCKS most probably competes with other PKC-&#x003b7; substrates, including MacMARCKS and proteins referred to as STICKs (substrates that interact with C-kinase) (Chapline et al., <xref rid="B11" ref-type="bibr">1998</xref>). Altogether, our data suggest that MARCKS activation is dependent on PKC-&#x003b7; function, and both proteins are involved in <italic>Burkholderia</italic>-induced host cell pathology following infection.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Intracellular survival and spread of pathogenic <italic>Burkholderia</italic> is dependent on PKC-&#x003b7; and MARCKS function. <bold>(A)</bold> A549 cells were treated with 20 nM siRNA targeting MARCKS or PKC-&#x003b7; for 72 h prior to infection with <italic>Bt</italic> CDC2721121 at MOI 50. After 2 h of infection, cells were treated with 250 &#x003bc;g/ml kanamycin for 3 h, and incubated overnight in antibiotic-free media. Cells were collected 24 h post-infection and lysed with 0.1% Triton to release the intracellular bacteria. Colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37&#x000b0;C. LDH activity was measured in conditioned media and is presented as fold increase in the 24 vs. 2 h post infection. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for CFU counts and relative LDH activity in samples treated with siRNA to MARCKS or PKC-&#x003b7;, compared to control samples (siR-CTL). <bold>(B)</bold> A549 cells were treated with 20 nM siRNA against MARCKS or with non-targeting (siR-CTL) siRNA 72 h prior to infection with <italic>Bt</italic> CDC2721121 at MOI 50. Cells were fixed 18 h post-infection, stained with Giemsa, and the percentage of MNGC formation was calculated relative to normal cells per field of view. The average and standard deviations were derived from at least 10 fields of view covering an entire 20 mm culture dish. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for % MNGC in samples treated with siRNA to MARCKS compared to samples treated with control siRNA (siR-CTL). The scale bar is 60 &#x003bc;M in length.</p></caption><graphic xlink:href="fcimb-07-00231-g0004"/></fig></sec><sec><title>PKC-&#x003b7; regulates MARCKS phosphorylation upon engagement of mannose receptors by unopsonized <italic>B. thailandensis</italic></title><p>Pathogen uptake via phagocytosis is initiated by a recognition event between a specific host receptor and microbial cell surface molecules, such as lipopolysaccharide or opsonins (e.g., antibodies) that coat the bacteria. Mannose receptors (MR) play a significant role in the uptake of unopsonized bacteria (Geier and Celli, <xref rid="B23" ref-type="bibr">2011</xref>), but have not yet been found to play a role in microbicidal phagocytic pathways (Astarie-Dequecker et al., <xref rid="B3" ref-type="bibr">1999</xref>). Interestingly, MARCKS was previously reported to function in the phagocytosis of zymosan particles that engage MRs (Carballo et al., <xref rid="B10" ref-type="bibr">1999</xref>). To investigate whether <italic>B. thailandensis CDC2721121</italic> can activate MARCKS phosphorylation via MR engagement, we quantified pMARCKS levels in A549 cells treated with purified mannan to saturate the MRs. A549 cells pre-incubated with mannan exhibited a ~1.5&#x02013;2-fold decrease in pMARCKS levels following infection with <italic>Bt</italic> CDC2721121, compared to infected cells not treated with mannan (CTL), suggesting that MARCKS phosphorylation is at least partly dependent on MR engagement by the pathogen (Figure <xref ref-type="fig" rid="F5">5A</xref>, light gray). Alternatively, coating <italic>Bt</italic> CDC2721121 with an opsonin, rabbit anti-<italic>B.th</italic> serum, to block potential interactions between MRs and the pathogen, resulted in ~2-fold reduction of pMARCKS levels in A549 cells. Notably, both conditions decreased the efficiency of <italic>Bt</italic> CDC2721121 infection, reducing the replication index of intracellular <italic>Bt</italic> CDC2721121 in A549 cells by ~2-fold (Figure <xref ref-type="fig" rid="F5">5A</xref>, dark gray). These data suggest that MARCKS phosphorylation is triggered upon interaction of <italic>Bt</italic> CDC2721121-associated cell surface molecular patterns (eg. mannan polysacharides) with lung epithelial A549 cell receptors, including MR.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Phagocytosis receptor usage determines the efficiency of intracellular <italic>Burkholderia</italic> proliferation. (A) A549 cells were (1) incubated with 3 mg/ml soluble mannan for 30 min and then infected with unopsonized <italic>Bt</italic> CDC2721121 at MOI 50, (2) not treated with mannan and infected with <italic>Bt</italic> CDC2721121 coated with anti-<italic>B.thailandensis</italic> rabbit serum (opson <italic>Bt</italic>), or (3) not treated with mannan and uninfected (CTL). pMARCKS levels in bacteria-infected cells were quantified and compared to uninfected cells. In parallel, A549 cells were collected after 2 h of infection for determination of intracellular bacterial counts. These cells were treated with 250 &#x003bc;g/ml kanamycin for 3 h to inhibit extracellular bacterial growth and incubated overnight in antibiotic-free media. At 24 h post-infection, a second set of samples were collected, and colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37&#x000b0;C. The replication index of intracellular <italic>Bt</italic> CDC2721121 was calculated as the CFU fold change at 24 vs. 2 h post-infection. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for fold change in pMARCKS and replication index in host cells treated with mannan or pathogen coated with serum, compared to CTL samples. <bold>(B)</bold> A549 and THP-1 cells were treated as described in <bold>(A)</bold>, and LDH activity was measured in conditioned media 2 h post infection. After treatment with kanamycin (250 &#x003bc;g/ml) for 3 h, host cells were incubated for 24 h in antibiotic-free media and a second LDH measurement was taken. Relative LDH activity was determined as fold change between the 24 h and 2 h time points post-infection. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for relative LDH activity in experimental samples compared to untreated (CTL) samples. <bold>(C)</bold> A549 cells were treated with 25 nM siRNA targeting MRC1 or with non-targeting (CTL) siRNA and were infected with unopsonized <italic>Bt</italic> CDC2721121 at MOI 50. At 1 h and 24 h post-infection, cells were lysed with 0.1% Triton, and colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37&#x000b0;C. The ratio of CFU corresponding to intracellular bacteria from siR-MRC1 treated cells vs. cells treated with non-targeting siRNA is shown for each time point. The average mean and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) in number of CFUs between 1 and 24 h.</p></caption><graphic xlink:href="fcimb-07-00231-g0005"/></fig><p>Consistent with these observations, both mannan pre-treatment and infection with serum-optimized <italic>Bt</italic> CDC2721121 had a positive effect on A549 host cell viability, as measured by a decrease in extracellular LDH activity (Figure <xref ref-type="fig" rid="F5">5B</xref>). In contrast, survival of THP-1 cells treated with mannan did not significantly differ from untreated cells (CTL) following infection. This difference in host cell survival between A549 (epithelial) and THP-1 (monocytic) cells upon mannan treatment is likely due to the lower expression levels of MR on monocytes prior to their differentiation into macrophages (Rouleux-Bonnin et al., <xref rid="B54" ref-type="bibr">1995</xref>; Wollenberg et al., <xref rid="B67" ref-type="bibr">2002</xref>). We also observed that serum-opsonized <italic>Bt</italic> CDC2721121 induced a rapid decline in THP-1 viability upon infection, suggesting activation of cell death mechanisms, possibly through Fc receptor (FcR) signaling triggered by antibody opsonins (Underhill and Ozinsky, <xref rid="B64" ref-type="bibr">2002</xref>). Finally, we siRNA-depleted MRC1 (mannose receptor C type 1, CD206) transcripts from A549 cells and observed ~60% reduction in bacterial uptake after 1 h post-infection, relative to host cells treated with non-targeting siRNA (Figure <xref ref-type="fig" rid="F5">5C</xref>). However, we detected no difference in the intracellular <italic>Bt</italic> CDC2721121 counts between siR-MRC1-treated and control A549 cells after 24 h of infection. These results suggest that mannose receptors facilitate initial <italic>B. thailandensis</italic> uptake but do not significantly contribute to the activation of cellular defense mechanisms that restrict intracellular bacterial growth over time.</p></sec><sec><title>PKC-&#x003b7; facilitates <italic>B. thailandensis</italic> escape into the host cytoplasm</title><p>To determine whether the opsonization state of <italic>Burkholderia</italic> can affect stimulation of macroautophagy, we quantified expression of ATG7, a regulator of autophagosome formation (Geng and Klionsky, <xref rid="B24" ref-type="bibr">2008</xref>), in response to infection with unopsonized and serum-opsonized <italic>Bt</italic> CDC2721121. We observed ~3-fold increase in ATG7 expression at 5 h post-infection of THP-1 cells with unopsonized <italic>Bt</italic> CDC2721121, but a ~70% decrease in ATG7 levels upon infection with serum-opsonized pathogen, relative to uninfected monocytes (Figure <xref ref-type="fig" rid="F6">6A</xref>, light gray), suggesting that unopsonized pathogen may preferentially activate autophagosome formation. We also observed a ~5-fold increase in MARCKS transcript levels in THP-1 cells infected with unopsonized <italic>Bt</italic> CDC2721121, whereas there was very little change in MARCKS levels in cells infected with opsonized bacteria (Figure <xref ref-type="fig" rid="F6">6A</xref>, dark gray). Based on our previous findings that MARCKS function was at least partially regulated by PKC-&#x003b7; (Figure <xref ref-type="fig" rid="F3">3B</xref>), we also examined a putative role for PKC-&#x003b7; in the regulation of MARCKS and ATG7 gene transcription. We found that both MARCKS and ATG7 transcript levels were reduced ~2- and ~5-fold, respectively, in cells depleted of PKC-&#x003b7;, compared to control siRNA-treated cells (CTL) upon infection with unopsonized <italic>Bt</italic> CDC2721121 (Figure <xref ref-type="fig" rid="F6">6B</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>Downregulation of PKC-&#x003b7; gene expression results in reduced cytoplasmic <italic>Burkholderia</italic> load and autophagy initiation. <bold>(A)</bold> A549 cells were infected with unopsonized or serum-coated <italic>Bt</italic> CDC2721121 (opson <italic>Bt</italic>) at MOI 50. Total RNA was isolated 5 h post infection, and transcript levels of ATG7 and MARCKS were quantified in infected vs. uninfected cells. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for RNA expression in infected host cells compared to uninfected samples. <bold>(B)</bold> A549 cells were treated with 20 nM siRNA targeting PKC-&#x003b7; or control siRNA (siR-CTL) for 72 h and then infected with unopsonized <italic>Bt</italic> CDC2721121 at MOI 50. Total RNA was isolated 18 h post infection and changes in gene expression profiles of PKC-&#x003b7;, MARCKS, and ATG7 were quantified relative to uninfected cells. The average and standard deviation from three independent experiments are shown. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for RNA expression in samples treated with siR-PKC-&#x003b7; compared to their cognate samples treated with control siRNA. <bold>(C)</bold> A549 cells stably expressing RFP-LC3B were infected with unopsonized <italic>Bt</italic> CDC2721121 at MOI 50 for 6 h or treated with 0.5 &#x003bc;M rapamycin and analyzed by fluorescent microscopy to image LC3-positive autophagosomes. Scale bar, 10 &#x003bc;m. <bold>(D,E)</bold> Quantifying autophagosomes and cytoplasmic <italic>Bt</italic> CDC2721121 in lung epithelial cells with imaging flow cytometry. A549-RFP-LC3B cells were treated with 20 nM siRNA against PKC-&#x003b7; or non-targeting siRNA (siR-CTL) for 72 h <italic>prior</italic> to infection with FITC-labeled <italic>Bt</italic> CDC2721121 at MOI 50. No drug or 10 &#x003bc;M rapamycin was added 3 h before bacterial infection for controls. Cells were treated with 250 &#x003bc;g/ml kanamycin after 2 h of infection and collected 6 h post-infection for analysis. Cells were fixed with 3% paraformaldehyde (pH 6), washed, and then analyzed by Amnis ImageStream<sup>X</sup>. The average number of RFP-LC3 spots was determined by the ratio of total RPF-positive puncta to the number of analyzed single cells. The average number of cytoplasmic bacteria per cell was determined by counting the FITC-positive spots in the green channel and not spots in the red channel divided by the total number of analyzed single cells. The average mean and standard deviation represent statistical analysis of 800 fluorescent positive cells per sample. The &#x0201c;<sup>*</sup>&#x0201d; denotes statistical significance (<italic>p</italic> &#x0003c; 0.05) for the number of cytoplasmic <italic>Burkholderia</italic> in cells depleted of PKC-&#x003b7; compared to untreated control cells (CTL).</p></caption><graphic xlink:href="fcimb-07-00231-g0006"/></fig><p>To investigate whether PKC-&#x003b7; may be linked to activation of host macroautophagy in response to <italic>B. thailandensis</italic> infection, we monitored autophagosome formation in A549 cells that stably expressed a RFP-tagged fusion to the key autophagy protein LC3/ATG8. We observed formation of RFP-LC3-labeled autophagosome vesicles 6 h after infection with unopsonized <italic>Bt</italic> CDC2721121, similar to treatment with rapamycin, a potent inducer of autophagy flux (Figure <xref ref-type="fig" rid="F6">6C</xref>). The average number of RFP-LC3-associated autophagosome vesicles in A549 cells increased &#x0003e;3-fold in infected compared to uninfected cells (Figure <xref ref-type="fig" rid="F6">6D</xref>). We observed that siRNA depletion of PKC-&#x003b7; did not significantly change the number of RFP-LC3-labeled vesicles in infected cells, compared to the untreated (CTL), rapamycin-treated, or siR-CTL-treated controls (Figure <xref ref-type="fig" rid="F6">6D</xref>). However, we did observe a &#x0003e;75% decrease in intracellular cytoplasmic pathogen that was not associated with RFP-LC3-labeled autophagosome vesicles in PKC-&#x003b7;-depleted A549 cells, compared to untreated (CTL) and siR-CTL treated cells (Figure <xref ref-type="fig" rid="F6">6E</xref>). Taken together, these results suggest that upon infection with unopsonized <italic>Burkholderia</italic>, PKC-&#x003b7; functions in phagocytic pathways that facilitate bacterial escape into the cytoplasm, which in turn activates host macroautophagy. Here, we demonstrate that inhibition of PKC-&#x003b7; function reduces the events of intracellular bacterial escape into the cytoplasm using the autophagosome flux activation as a reporter marker.</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Intracellular pathogens exploit different virulence mechanisms and multiple host factors for efficient invasion, replication, and spread during infection (Hong-Geller and Micheva-Viteva, <xref rid="B29" ref-type="bibr">2010</xref>; Micheva-Viteva et al., <xref rid="B42" ref-type="bibr">2013</xref>; Li et al., <xref rid="B35" ref-type="bibr">2016</xref>). We have performed a RNAi screen and identified 35 genes from the human kinome that play an essential role in the infection of <italic>B. thailandensis</italic>, a close relative of the naturally multidrug-resistant intracellular biothreat pathogen, <italic>B. pseudomallei</italic>. In this study, we have focused on the role of the novel DAG-dependent, Ca<sup>2+</sup>-independent PKC-&#x003b7; isoform in promoting intracellular survival of <italic>Burkholderia</italic> in host cells. The PKC family consists of at least 10 isoforms classified as conventional, novel, and atypical, depending on the requirement for DAG and Ca<sup>2+</sup> for activation. Atypical DAG- and Ca<sup>2+</sup>-independent PKC isoforms (e.g., PKC- &#x003b6;) have also previously been implicated in phagosomal escape and intracellular survival of <italic>Listeria</italic> and <italic>Plasmodium</italic> sporozoites, suggesting that Ca<sup>2+</sup>-independent novel and atypical PKC isoforms can mediate intracellular pathogen infection (Prudencio et al., <xref rid="B51" ref-type="bibr">2008</xref>; Jiwani et al., <xref rid="B30" ref-type="bibr">2012</xref>). Conventional DAG- and Ca<sup>2+</sup>-dependent PKC isoforms (e.g., PKC-&#x003b1;) regulate actin cytoskeleton dynamics and antimicrobial immune responses, but were not identified in our screen. We had further observed that a dominant-negative variant of PKC-&#x003b1; did not significantly affect host cell survival upon <italic>B. thailandensis</italic> infection. Specific roles for PKC isoforms in CD40 signaling and macrophage infection by <italic>Leishmania major</italic> have been reported (Sudan et al., <xref rid="B60" ref-type="bibr">2012</xref>). Infection of macrophages with <italic>L. major</italic> was found to enhance PKC&#x003b4;/&#x003b6;/&#x003bb;&#x02013;dependent activation of ERK1/2 phosphorylation and <italic>Leishmania</italic> growth, but impair the functions of PKC&#x003b1;/&#x003b2;/&#x003b5; responsible for p38MAPK phosphorylation and parasite killing, thus defining differential roles for PKC isoforms in immune homeostasis.</p><p>This study links pathogen opsonization with the divergent functions of PKC isoforms. Our results show that infection with unopsonized <italic>B. thailandensis</italic> specifically activates PKC-&#x003b7; regulation of MARCKS function on both transcriptional (expression) and post-transcriptional (phosphorylation) levels to enable pathogen survival within the host. We observed that inhibition of PKC-&#x003b7; or MARCKS function by siRNA or functional mutant expression reduced the efficiency of <italic>Bt</italic> CDC2721121 infection in A549 cells. Infection with <italic>Y. enterocolitica</italic> also led to an increase in MARCKS phosphorylation, suggesting that multiple Gram-negative pathogens can activate the PKC-&#x003b7;/MARCKS pathway during infection. MARCKS, a phosphorylation target of PKC, has itself been previously linked to membrane trafficking and actin dynamics. Receptor-dependent PKC stimulation regulates trafficking of MARCKS between the plasma membrane, LAMP-1&#x02013;positive lysosomes (Allen and Aderem, <xref rid="B1" ref-type="bibr">1995a</xref>), and mucin granules (Li et al., <xref rid="B36" ref-type="bibr">2001</xref>). Formation of F-actin-rich lamellipodia is dependent on the dephosphorylation and translocation of MARCKS to lipid rafts, causing the recruitment of &#x003b2;-actin to membrane microdomains (Yamaguchi et al., <xref rid="B69" ref-type="bibr">2009</xref>). Moreover, a 24 aa peptide derived from the N-terminus of MARCKS was shown to block mucus secretion in a mouse model of asthma, further implicating MARCKS function in actin-mediated secretion (Singer et al., <xref rid="B57" ref-type="bibr">2004</xref>).</p><p>Host cell surface receptors, such as MR or FcR, can mediate bacterial uptake via recognition of mannan or antibody opsonins, respectively, on the pathogen cell surface. Interestingly, macrophages and fibroblasts isolated from MARCKS-knockout mouse embryos exhibited a decrease in only the MR-mediated uptake of zymosan-coated particles compared to wild type cells, thus linking MR and MARCKS functions in phagocytosis (Underhill et al., <xref rid="B63" ref-type="bibr">1998</xref>; Carballo et al., <xref rid="B10" ref-type="bibr">1999</xref>). We find that either saturation of host mannose receptors with mannan or coating of pathogen with anti-sera to block surface interactions and re-direct phagocytic receptor usage leads to a decrease in the replication index of <italic>B. thailandensis</italic> in A549 cells, suggesting that MR at least partly mediates the uptake and intracellular replication of unopsonized <italic>B. thailandensis</italic>. We also demonstrate that PKC-&#x003b7; is required for the intracellular survival of unopsonized <italic>B. thailandensis</italic> through the MR-MARCKS pathway.</p><p>The results presented here further enhance our understanding of the molecular machinery that regulates phagocytosis (Figure <xref ref-type="fig" rid="F7">7</xref>). It has been previously demonstrated that the PKC isoforms required for phagocytosis appear to be different in monocytes and mature macrophages. In monocytes Fc&#x003b3;RI stimulation was found to increase PKC activity corresponding to the membrane translocation of the Ca <sup>2+</sup>-independent PKC isoforms &#x003b4;, &#x003b5;, and &#x003b6; while Fc&#x003b3;RI stimulation in monocyte-differentiated macrophages involved PKC activity that corresponded to the membrane translocation of the PKC isoforms &#x003b1;, &#x003b2;, and &#x003b3; (Melendez et al., <xref rid="B39" ref-type="bibr">1999</xref>). To date no particular role has been assigned to the novel isoform PKC-&#x003b7; in Fc&#x003b3;RI signaling. We observed that infection of undifferentiated monocytic THP-1 cells with bacteria coated with anti-<italic>B. thailandensis</italic> serum resulted in reduced expression of ATG7 and MARCKS, genes we found to be at least partially regulated by the Ca<sup>2+</sup>-independent PKC-&#x003b7; (Figure <xref ref-type="fig" rid="F6">6</xref>). Our data suggest that this novel isoform has a stronger effect on phagocytic pathways initiated by receptors recognizing pathogen associated molecular patterns in contrast to phagocytosis stimulated by Fc&#x003b3;R intearction with IgG opsonized bacteria.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p>Coating of bacteria with opsonin determines receptor usage and the involvement of protein kinase C (PKC) isoforms in the regulation of phagocytosis-associated cell responses. Immunoglobulin G-opsonized bacteria triggers Fc&#x003b3;Rs-mediated phagocytosis engaging classical PKC isoform signaling pathways leading to pro-inflammatory cell responses, including the respiratory burst leading to efficient killing of bacteria within the lysosomes (Breton and Descoteaux, <xref rid="B5" ref-type="bibr">2000</xref>; Dekker et al., <xref rid="B20" ref-type="bibr">2000</xref>; Sudan et al., <xref rid="B60" ref-type="bibr">2012</xref>). Interaction of bacterial glycoproteins with the host cell mannose receptor C-type 1, MRC1, stimulates signaling pathways regulated by the Ca<sup>2+</sup>-independent PKC isoforms resulting in escape of bacteria from the phagosome into the cytosol. Our hypothesis is that PKC inhibitors with selectivity to the novel, Ca<sup>2+</sup>-independent isoforms have the potential to act as host-directed antimicrobials blocking pathogen escape from phagosome destruction.</p></caption><graphic xlink:href="fcimb-07-00231-g0007"/></fig><p>In response to pathogen invasion, the host will attempt to restrict intracellular bacterial proliferation by mounting defense mechanisms such as macroautophagy (Romao et al., <xref rid="B53" ref-type="bibr">2013</xref>; Munz, <xref rid="B46" ref-type="bibr">2014</xref>), a process by which cytoplasmic constituents and dysfunctional organelles are recycled in eukaryotic cells (Choy and Roy, <xref rid="B14" ref-type="bibr">2013</xref>; Pareja and Colombo, <xref rid="B50" ref-type="bibr">2013</xref>). While autophagy can effectively inhibit intracellular survival of some bacteria (Gutierrez et al., <xref rid="B27" ref-type="bibr">2004</xref>; Nakagawa et al., <xref rid="B47" ref-type="bibr">2004</xref>), <italic>Burkholderia</italic> species have been shown to subvert this host defense mechanism to establish persistent infection (Colombo et al., <xref rid="B15" ref-type="bibr">2006</xref>; Ogawa and Sasakawa, <xref rid="B48" ref-type="bibr">2006</xref>; Rodrigues et al., <xref rid="B52" ref-type="bibr">2007</xref>). Induction of autophagy in murine macrophages can suppress the intracellular survival of pathogenic <italic>B. pseudomallei</italic>, which in turn, induces the expression of the Type 3 secretion system (T3SS) effector BopA to evade autophagy (Cullinane et al., <xref rid="B16" ref-type="bibr">2008</xref>). We observed that expression of ATG7, a mediator of autophagy, is upregulated upon infection with unopsonized <italic>B. thailandensis</italic>, suggesting that uptake of unopsonized pathogen can lead to phagosomal escape that triggers autophagy. Furthermore, siRNA-mediated depletion of PKC-&#x003b7; significantly inhibited ATG7 gene expression levels. Finally, our finding that the counts of <italic>B. thailandensis</italic> not associated with phagosomes was reduced upon PKC-&#x003b7; depletion, whereas phagosome vesicle formation remained unchanged, suggests that PKC-&#x003b7; plays an indirect role in the activation of autophagosome flux, likely by facilitating phagocytic pathways that promote <italic>Burkholderia</italic> escape into the cytoplasm.</p><p>All together, our results support a model in which PKC-&#x003b7;/MARCKS signaling can promote intracellular survival of unopsonized <italic>B. thailandensis</italic>, at least partly through activation of MR. Isoform-specific, PKC-targeted immunotherapy based on <italic>in vivo</italic> gene silencing has been reported to protect susceptible BALB/c mice from <italic>L. major</italic> infection (Sudan et al., <xref rid="B60" ref-type="bibr">2012</xref>). Highly specific small molecule inhibitors against the novel PKC-&#x003b7;/&#x003b6;/&#x003b5; isoforms, with ~100-fold selectivity over the conventional PKC &#x003b1;/&#x003b2; isoforms, have been identified (van Eis et al., <xref rid="B65" ref-type="bibr">2011</xref>) and could be tested as potential modulators of cellular innate defense against intracellular pathogens. Thus, small molecule inhibitors with selectivity to the novel PKC isoform- group may have the potential to act as host-directed antimicrobials blocking pathogen escape from host-mediated destruction. Such agents may also contribute to the reduction of antimicrobial resistance to conventional antibiotics (Czyz et al., <xref rid="B19" ref-type="bibr">2014</xref>).</p></sec><sec id="s5"><title>Author contributions</title><p>Conceived and designed the experiments: SM and EH. Performed the experiments: SM, YS, KG, and TW. Analyzed the data: SM and EH. Wrote the paper: SM and EH.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We thank Dr. Mary Burtnick (University of Southern Alabama) for the <italic>B. thailandensis</italic> DW503 strain and the BHR4-GFP plasmid. We also thank Dr. Kristy Nowak-Lovato and Hongzhao Tian for technical assistance and Dr. Paul Brett, (University of Southern Alabama) for the rabbit anti-serum to <italic>B. thailandensis</italic>.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was funded by a grant to EH (CBS.MEDBIO.02.10.LA.016) from the Defense Threat Reduction Agency (DTRA) of the Department of Defense (DoD).</p></fn></fn-group><sec sec-type="supplementary-material" id="s6"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fcimb.2017.00231/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fcimb.2017.00231/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="DataSheet1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>L. H.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group> (<year>1995a</year>). <article-title>Protein kinase C regulates MARCKS cycling between the plasma membrane and lysosomes in fibroblasts</article-title>. <source>EMBO J.</source>
<volume>14</volume>, <fpage>1109</fpage>&#x02013;<lpage>1121</lpage>. <?supplied-pmid 7720702?><pub-id pub-id-type="pmid">7720702</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>L. H.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group> (<year>1995b</year>). <article-title>A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages</article-title>. <source>J. Exp. Med.</source>
<volume>182</volume>, <fpage>829</fpage>&#x02013;<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1084/jem.182.3.829</pub-id><?supplied-pmid 7650489?><pub-id pub-id-type="pmid">7650489</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astarie-Dequecker</surname><given-names>C.</given-names></name><name><surname>N'Diaye</surname><given-names>E.</given-names></name><name><surname>Le Cabec</surname><given-names>V.</given-names></name><name><surname>Rittig</surname><given-names>M.</given-names></name><name><surname>Prandi</surname><given-names>J.</given-names></name><name><surname>Maridonneau-Parini</surname><given-names>I.</given-names></name></person-group> (<year>1999</year>). <article-title>The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages</article-title>. <source>Infect. Immun.</source>
<volume>67</volume>, <fpage>469</fpage>&#x02013;<lpage>477</lpage>.<pub-id pub-id-type="pmid">9916047</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>T. J.</given-names></name><name><surname>Blaney</surname><given-names>D. D.</given-names></name><name><surname>Doker</surname><given-names>T. J.</given-names></name><name><surname>Gee</surname><given-names>J. E.</given-names></name><name><surname>Elrod</surname><given-names>M. G.</given-names></name><name><surname>Walke</surname><given-names>H. T.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>A review of melioidosis cases in the Americas</article-title>. <source>Am. J. Trop. Med. Hyg.</source>
<volume>93</volume>, <fpage>1134</fpage>&#x02013;<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.15-0405</pub-id><?supplied-pmid 26458779?><pub-id pub-id-type="pmid">26458779</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breton</surname><given-names>A.</given-names></name><name><surname>Descoteaux</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>276</volume>, <fpage>472</fpage>&#x02013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2000.3511</pub-id><?supplied-pmid 11027499?><pub-id pub-id-type="pmid">11027499</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtnick</surname><given-names>M.</given-names></name><name><surname>Bolton</surname><given-names>A.</given-names></name><name><surname>Brett</surname><given-names>P.</given-names></name><name><surname>Watanabe</surname><given-names>D.</given-names></name><name><surname>Woods</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic <italic>Burkholderia</italic> spp. facilitates TnphoA mutagenesis</article-title>. <source>Microbiology</source>
<volume>147</volume>, <fpage>111</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-147-1-111</pub-id><?supplied-pmid 11160805?><pub-id pub-id-type="pmid">11160805</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtnick</surname><given-names>M. N.</given-names></name><name><surname>Brett</surname><given-names>P. J.</given-names></name><name><surname>Harding</surname><given-names>S. V.</given-names></name><name><surname>Ngugi</surname><given-names>S. A.</given-names></name><name><surname>Ribot</surname><given-names>W. J.</given-names></name><name><surname>Deshazer</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei</article-title>. <source>Infect. Immun.</source>
<volume>79</volume>, <fpage>1512</fpage>&#x02013;<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01218-10</pub-id><?supplied-pmid 21300775?><pub-id pub-id-type="pmid">21300775</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtnick</surname><given-names>M. N.</given-names></name><name><surname>Brett</surname><given-names>P. J.</given-names></name><name><surname>Nair</surname><given-names>V.</given-names></name><name><surname>Warawa</surname><given-names>J. M.</given-names></name><name><surname>Woods</surname><given-names>D. E.</given-names></name><name><surname>Gherardini</surname><given-names>F. C.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Burkholderia pseudomallei</italic> type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages</article-title>. <source>Infect. Immun.</source>
<volume>76</volume>, <fpage>2991</fpage>&#x02013;<lpage>3000</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00263-08</pub-id><?supplied-pmid 18443088?><pub-id pub-id-type="pmid">18443088</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtnick</surname><given-names>M. N.</given-names></name><name><surname>DeShazer</surname><given-names>D.</given-names></name><name><surname>Nair</surname><given-names>V.</given-names></name><name><surname>Gherardini</surname><given-names>F. C.</given-names></name><name><surname>Brett</surname><given-names>P. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages</article-title>. <source>Infect. Immun.</source>
<volume>78</volume>, <fpage>88</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00985-09</pub-id><?supplied-pmid 19884331?><pub-id pub-id-type="pmid">19884331</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carballo</surname><given-names>E.</given-names></name><name><surname>Pitterle</surname><given-names>D.</given-names></name><name><surname>Stumpo</surname><given-names>D.</given-names></name><name><surname>Sperling</surname><given-names>R.</given-names></name><name><surname>Blackshear</surname><given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Phagocytic and macropinocytic activity in MARCKS-deficient macrophages and fibroblasts</article-title>. <source>Am. J. Physiol.</source>
<volume>277</volume>, <fpage>C163</fpage>&#x02013;<lpage>C173</lpage>. <?supplied-pmid 10409119?><pub-id pub-id-type="pmid">10409119</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapline</surname><given-names>C. C. J.</given-names></name><name><surname>Tobin</surname><given-names>H.</given-names></name><name><surname>Hulmes</surname><given-names>J.</given-names></name><name><surname>Crabb</surname><given-names>J.</given-names></name><name><surname>Jaken</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling</article-title>. <source>J. Biol. Chem.</source>
<volume>273</volume>, <fpage>19482</fpage>&#x02013;<lpage>19489</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.31.19482</pub-id><?supplied-pmid 9677369?><pub-id pub-id-type="pmid">9677369</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charoensap</surname><given-names>J.</given-names></name><name><surname>Utaisincharoen</surname><given-names>P.</given-names></name><name><surname>Engering</surname><given-names>A.</given-names></name><name><surname>Sirisinha</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Differential intracellular fate of <italic>Burkholderia pseudomallei</italic> 844 and <italic>Burkholderia thailandensis</italic> UE5 in human monocyte-derived dendritic cells and macrophages</article-title>. <source>BMC Immunol.</source>
<volume>10</volume>:<fpage>20</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2172-10-20</pub-id><?supplied-pmid 19397822?><pub-id pub-id-type="pmid">19397822</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>C.</given-names></name><name><surname>Monack</surname><given-names>D.</given-names></name><name><surname>Nathan</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Genome wide transcriptome profiling of a murine acute melioidosis model reveals insights into how <italic>Burkholderia psuedomallei</italic> overcomes host innate immunity</article-title>. <source>BMC Genomics</source>
<volume>11</volume>:<fpage>672</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-11-672</pub-id><?supplied-pmid 21110886?><pub-id pub-id-type="pmid">21110886</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>A.</given-names></name><name><surname>Roy</surname><given-names>C. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Autophagy and bacterial infection: an evolving arms race</article-title>. <source>Trends Microbiol.</source>
<volume>21</volume>, <fpage>451</fpage>&#x02013;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2013.06.009</pub-id><?supplied-pmid 23880062?><pub-id pub-id-type="pmid">23880062</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>M. I.</given-names></name><name><surname>Gutierrez</surname><given-names>M. G.</given-names></name><name><surname>Romano</surname><given-names>P. S.</given-names></name></person-group> (<year>2006</year>). <article-title>The two faces of autophagy: coxiella and mycobacterium</article-title>. <source>Autophagy</source>
<volume>2</volume>, <fpage>162</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.4161/auto.2827</pub-id><?supplied-pmid 16874070?><pub-id pub-id-type="pmid">16874070</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullinane</surname><given-names>M.</given-names></name><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Lazar-Adler</surname><given-names>N.</given-names></name><name><surname>Tra</surname><given-names>T.</given-names></name><name><surname>Wolvetang</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Stimulation of autophagy suppresses the intracellular survival of <italic>Burkholderia pseudomallei</italic> in mammalian cell lines</article-title>. <source>Autophagy</source>
<volume>4</volume>, <fpage>744</fpage>&#x02013;<lpage>753</lpage>. <pub-id pub-id-type="doi">10.4161/auto.6246</pub-id><?supplied-pmid 18483470?><pub-id pub-id-type="pmid">18483470</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currie</surname><given-names>B. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment</article-title>. <source>Semin. Respir. Crit. Care Med.</source>
<volume>36</volume>, <fpage>111</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1055/s-0034-1398389</pub-id><?supplied-pmid 25643275?><pub-id pub-id-type="pmid">25643275</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currie</surname><given-names>B. J.</given-names></name><name><surname>Ward</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>A. C.</given-names></name></person-group> (<year>2010</year>). <article-title>The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study</article-title>. <source>PLoS Negl. Trop. Dis.</source>
<volume>4</volume>:<fpage>e900</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0000900</pub-id><?supplied-pmid 21152057?><pub-id pub-id-type="pmid">21152057</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czyz</surname><given-names>D. M.</given-names></name><name><surname>Potluri</surname><given-names>L. P.</given-names></name><name><surname>Jain-Gupta</surname><given-names>N.</given-names></name><name><surname>Riley</surname><given-names>S. P.</given-names></name><name><surname>Martinez</surname><given-names>J. J.</given-names></name><name><surname>Gabay</surname><given-names>J. E.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens</article-title>. <source>MBio</source>
<volume>5</volume>, <fpage>e01534</fpage>&#x02013;<lpage>e01514</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.01534-14</pub-id><?supplied-pmid 25073644?><pub-id pub-id-type="pmid">25073644</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>L. V.</given-names></name><name><surname>Leitges</surname><given-names>M.</given-names></name><name><surname>Altschuler</surname><given-names>G.</given-names></name><name><surname>Mistry</surname><given-names>N.</given-names></name><name><surname>McDermott</surname><given-names>A.</given-names></name><name><surname>Roes</surname><given-names>J. W.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils</article-title>. <source>Biochem J.</source>
<volume>347</volume>(<issue>Pt 1</issue>), <fpage>285</fpage>&#x02013;<lpage>289</lpage>. <?supplied-pmid 10727429?><pub-id pub-id-type="pmid">10727429</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doker</surname><given-names>T. J.</given-names></name><name><surname>Quinn</surname><given-names>C. L.</given-names></name><name><surname>Salehi</surname><given-names>E. D.</given-names></name><name><surname>Sherwood</surname><given-names>J. J.</given-names></name><name><surname>Benoit</surname><given-names>T. J.</given-names></name><name><surname>Glass Elrod</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Fatal <italic>Burkholderia pseudomallei</italic> infection initially reported as a Bacillus species, Ohio, 2013</article-title>. <source>Am. J. Trop. Med. Hyg.</source>
<volume>91</volume>, <fpage>743</fpage>&#x02013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.14-0172</pub-id><?supplied-pmid 25092821?><pub-id pub-id-type="pmid">25092821</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galyov</surname><given-names>E. E.</given-names></name><name><surname>Brett</surname><given-names>P. J.</given-names></name><name><surname>DeShazer</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Molecular insights into <italic>Burkholderia pseudomallei</italic> and <italic>Burkholderia mallei</italic> pathogenesis</article-title>. <source>Annu. Rev. Microbiol.</source>
<volume>64</volume>, <fpage>495</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.112408.134030</pub-id><?supplied-pmid 20528691?><pub-id pub-id-type="pmid">20528691</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geier</surname><given-names>H.</given-names></name><name><surname>Celli</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Phagocytic receptors dictate phagosomal escape and intracellular proliferation of</article-title>
<source>Francisella tularensis. Infect. Immun.</source>
<volume>79</volume>, <fpage>2204</fpage>&#x02013;<lpage>2214</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01382-10</pub-id><?supplied-pmid 21422184?><pub-id pub-id-type="pmid">21422184</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>J.</given-names></name><name><surname>Klionsky</surname><given-names>D. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. Protein modifications: beyond the usual suspects' review series</article-title>. <source>EMBO Rep.</source>
<volume>9</volume>, <fpage>859</fpage>&#x02013;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2008.163</pub-id><?supplied-pmid 18704115?><pub-id pub-id-type="pmid">18704115</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>M. B.</given-names></name><name><surname>Gee</surname><given-names>J. E.</given-names></name><name><surname>Steigerwalt</surname><given-names>A. G.</given-names></name><name><surname>Cavuoti</surname><given-names>D.</given-names></name><name><surname>Barton</surname><given-names>T.</given-names></name><name><surname>Wilkins</surname><given-names>P. P.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Pneumonia and septicemia caused by <italic>Burkholderia thailandensis</italic> in the United States</article-title>. <source>J. Clin. Microbiol.</source>
<volume>44</volume>, <fpage>4601</fpage>&#x02013;<lpage>4604</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.01585-06</pub-id><?supplied-pmid 17050819?><pub-id pub-id-type="pmid">17050819</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Cullinane</surname><given-names>M.</given-names></name><name><surname>Treerat</surname><given-names>P.</given-names></name><name><surname>Ramm</surname><given-names>G.</given-names></name><name><surname>Prescott</surname><given-names>M.</given-names></name><name><surname>Adler</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>The <italic>Burkholderia pseudomallei</italic> type III secretion system and BopA are required for evasion of LC3-associated phagocytosis</article-title>. <source>PLoS ONE</source>
<volume>6</volume>:<fpage>e17852</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0017852</pub-id><?supplied-pmid 21412437?><pub-id pub-id-type="pmid">21412437</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>M. G.</given-names></name><name><surname>Master</surname><given-names>S. S.</given-names></name><name><surname>Singh</surname><given-names>S. B.</given-names></name><name><surname>Taylor</surname><given-names>G. A.</given-names></name><name><surname>Colombo</surname><given-names>M. I.</given-names></name><name><surname>Deretic</surname><given-names>V.</given-names></name></person-group> (<year>2004</year>). <article-title>Autophagy is a defense mechanism inhibiting BCG and <italic>Mycobacterium tuberculosis</italic> survival in infected macrophages</article-title>. <source>Cell</source>
<volume>119</volume>, <fpage>753</fpage>&#x02013;<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.11.038</pub-id><?supplied-pmid 15607973?><pub-id pub-id-type="pmid">15607973</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraga</surname><given-names>A.</given-names></name><name><surname>West</surname><given-names>T. E.</given-names></name><name><surname>Brittnacher</surname><given-names>M. J.</given-names></name><name><surname>Skerrett</surname><given-names>S. J.</given-names></name><name><surname>Miller</surname><given-names>S. I.</given-names></name></person-group> (<year>2008</year>). <source>Burkholderia thailandensis</source> as a model system for the study of the virulence-associated type III secretion system of <source>Burkholderia pseudomallei. Infect. Immun.</source>
<volume>76</volume>, <fpage>5402</fpage>&#x02013;<lpage>5411</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00626-08</pub-id><?supplied-pmid 18779342?><pub-id pub-id-type="pmid">18779342</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong-Geller</surname><given-names>E.</given-names></name><name><surname>Micheva-Viteva</surname><given-names>S. N.</given-names></name></person-group> (<year>2010</year>). <article-title>Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection</article-title>. <source>Curr. Drug Discov. Technol.</source>
<volume>7</volume>, <fpage>86</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.2174/157016310793180657</pub-id><?supplied-pmid 20836760?><pub-id pub-id-type="pmid">20836760</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiwani</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Dowd</surname><given-names>G.</given-names></name><name><surname>Gianfelice</surname><given-names>A. P.</given-names></name><name><surname>Gavicheria</surname><given-names>B.</given-names></name><name><surname>Ireton</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Identification of components of the host type IA phosphoinositide 3-kinase pathway that promote interanlization of <italic>Listeria monocytogenes</italic></article-title>. <source>Infect. Immun.</source>
<volume>80</volume>, <fpage>1252</fpage>&#x02013;<lpage>1266</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.06082-11</pub-id><?supplied-pmid 22158742?><pub-id pub-id-type="pmid">22158742</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>A. L.</given-names></name><name><surname>Beveridge</surname><given-names>T. J.</given-names></name><name><surname>Woods</surname><given-names>D. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Intracellular survival of <italic>Burkholderia pseudomallei</italic></article-title>. <source>Infect. Immun.</source>
<volume>64</volume>, <fpage>782</fpage>&#x02013;<lpage>790</lpage>. <?supplied-pmid 8641782?><pub-id pub-id-type="pmid">8641782</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>S.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Yoshimori</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3</article-title>. <source>Autophagy</source>
<volume>3</volume>, <fpage>452</fpage>&#x02013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.4161/auto.4451</pub-id><?supplied-pmid 17534139?><pub-id pub-id-type="pmid">17534139</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijl</surname><given-names>C.</given-names></name><name><surname>Savage</surname><given-names>N. D.</given-names></name><name><surname>Marsman</surname><given-names>M.</given-names></name><name><surname>Tuin</surname><given-names>A. W.</given-names></name><name><surname>Janssen</surname><given-names>L.</given-names></name><name><surname>Neefjes</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1</article-title>. <source>Nature</source>
<volume>450</volume>, <fpage>725</fpage>&#x02013;<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1038/nature06345</pub-id><?supplied-pmid 18046412?><pub-id pub-id-type="pmid">18046412</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunyanee</surname><given-names>C.</given-names></name><name><surname>Kamjumphol</surname><given-names>W.</given-names></name><name><surname>Taweechaisupapong</surname><given-names>S.</given-names></name><name><surname>Kanthawong</surname><given-names>S.</given-names></name><name><surname>Wongwajana</surname><given-names>S.</given-names></name><name><surname>Wonggratanacheewin</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title><italic>Burkholderia pseudomallei</italic> biofilm promotes adhesion, internalization and stimulates proinflammatory cytokines in human epithelial A549 cells</article-title>. <source>PLoS ONE</source>
<volume>11</volume>:<fpage>e0160741</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0160741</pub-id><?supplied-pmid 27529172?><pub-id pub-id-type="pmid">27529172</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Hennelly</surname><given-names>S.</given-names></name><name><surname>Stubben</surname><given-names>C.</given-names></name><name><surname>Micheva-Viteva</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Shou</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Functional and structural analysis of a highly-expressed <italic>Yersinia pestis</italic> small RNA following infection of cultured macrophages</article-title>. <source>PLoS ONE</source>
<volume>11</volume>:<fpage>e0168915</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0168915</pub-id><?supplied-pmid 28030576?><pub-id pub-id-type="pmid">28030576</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>L.</given-names></name><name><surname>Spizz</surname><given-names>G.</given-names></name><name><surname>Adler</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells <italic>in vitro</italic></article-title>. <source>J. Biol. Chem.</source>
<volume>276</volume>, <fpage>40982</fpage>&#x02013;<lpage>40990</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M105614200</pub-id><?supplied-pmid 11533058?><pub-id pub-id-type="pmid">11533058</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limmathurotsakul</surname><given-names>D.</given-names></name><name><surname>Golding</surname><given-names>N.</given-names></name><name><surname>Dance</surname><given-names>D. A.</given-names></name><name><surname>Messina</surname><given-names>J. P.</given-names></name><name><surname>Pigott</surname><given-names>D. M.</given-names></name><name><surname>Hay</surname><given-names>S. I.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Predicted global distribution of <italic>Burkholderia pseudomallei</italic> and burden of melioidosis</article-title>. <source>Nat. Microbiol.</source>
<volume>1</volume>, <fpage>15008</fpage>
<pub-id pub-id-type="doi">10.1038/nmicrobiol.2015.8</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariappan</surname><given-names>V.</given-names></name><name><surname>Vellasamy</surname><given-names>K.</given-names></name><name><surname>Thimma</surname><given-names>J.</given-names></name><name><surname>Hashim</surname><given-names>O.</given-names></name><name><surname>Vadivelu</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Infection of <italic>Burkholderia cepacia</italic> induces homeostatic response in the host for their prolonged survival: the microarray perspective</article-title>. <source>PLoS ONE</source>
<volume>8</volume>:<fpage>e77418</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0077418</pub-id><pub-id pub-id-type="pmid">24116227</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melendez</surname><given-names>A. J.</given-names></name><name><surname>Harnett</surname><given-names>M. M.</given-names></name><name><surname>Allen</surname><given-names>J. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Differentiation-dependent switch in protein kinase C isoenzyme activation by FcgammaRI, the human high-affinity receptor for immunoglobulin G</article-title>. <source>Immunology</source>
<volume>96</volume>, <fpage>457</fpage>&#x02013;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2567.1999.00689.x</pub-id><?supplied-pmid 10233728?><pub-id pub-id-type="pmid">10233728</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memisevic</surname><given-names>V.</given-names></name><name><surname>Zavaljevski</surname><given-names>N.</given-names></name><name><surname>Pieper</surname><given-names>R.</given-names></name><name><surname>Rajagopala</surname><given-names>S. V.</given-names></name><name><surname>Kwon</surname><given-names>K.</given-names></name><name><surname>Wallqvist</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Novel <italic>Burkholderia mallei</italic> virulence factors linked to specific host-pathogen protein interactions</article-title>. <source>Mol. Cell. Proteomics</source>
<volume>12</volume>, <fpage>3036</fpage>&#x02013;<lpage>3051</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M113.029041</pub-id><?supplied-pmid 23800426?><pub-id pub-id-type="pmid">23800426</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memisevic</surname><given-names>V.</given-names></name><name><surname>Zavaljevski</surname><given-names>N.</given-names></name><name><surname>Rajagopala</surname><given-names>S. V.</given-names></name><name><surname>Kwon</surname><given-names>K.</given-names></name><name><surname>Pieper</surname><given-names>R.</given-names></name><name><surname>Wallqvist</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Mining host-pathogen protein interactions to characterize <italic>Burkholderia mallei</italic> infectivity mechanisms</article-title>. <source>PLoS Comput. Biol.</source>
<volume>11</volume>:<fpage>e1004088</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004088</pub-id><?supplied-pmid 25738731?><pub-id pub-id-type="pmid">25738731</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micheva-Viteva</surname><given-names>S.</given-names></name><name><surname>Shou</surname><given-names>Y.</given-names></name><name><surname>Nowak-Lovato</surname><given-names>K.</given-names></name><name><surname>Rector</surname><given-names>K.</given-names></name><name><surname>Hong-Geller</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response</article-title>. <source>BMC Microbiol.</source>
<volume>13</volume>:<fpage>249</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2180-13-249</pub-id><?supplied-pmid 24206648?><pub-id pub-id-type="pmid">24206648</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mochly-Rosen</surname><given-names>D.</given-names></name><name><surname>Das</surname><given-names>K.</given-names></name><name><surname>Grimes</surname><given-names>K. V.</given-names></name></person-group> (<year>2012</year>). <article-title>Protein kinase C, an elusive therapeutic target?</article-title>
<source>Nat. Rev. Drug Discov.</source>
<volume>11</volume>, <fpage>937</fpage>&#x02013;<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3871</pub-id><?supplied-pmid 23197040?><pub-id pub-id-type="pmid">23197040</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>R. A.</given-names></name><name><surname>DeShazer</surname><given-names>D.</given-names></name><name><surname>Reckseidler</surname><given-names>S.</given-names></name><name><surname>Weissman</surname><given-names>A.</given-names></name><name><surname>Woods</surname><given-names>D. E.</given-names></name></person-group> (<year>1999</year>). <article-title>Efflux-mediated aminoglycoside and macrolide resistance</article-title> in <source>Burkholderia pseudomallei. Antimicrob. Agents Chemother.</source>
<volume>43</volume>, <fpage>465</fpage>&#x02013;<lpage>470</lpage>. <?supplied-pmid 10049252?><pub-id pub-id-type="pmid">10049252</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muangsombut</surname><given-names>V.</given-names></name><name><surname>Suparak</surname><given-names>S.</given-names></name><name><surname>Pumirat</surname><given-names>P.</given-names></name><name><surname>Damnin</surname><given-names>S.</given-names></name><name><surname>Vattanaviboon</surname><given-names>P.</given-names></name><name><surname>Thongboonkerd</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Inactivation of <italic>Burkholderia pseudomallei</italic> bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles</article-title>. <source>Arch. Microbiol.</source>
<volume>190</volume>, <fpage>623</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1007/s00203-008-0413-3</pub-id><?supplied-pmid 18654761?><pub-id pub-id-type="pmid">18654761</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munz</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Regulation of innate immunity by the molecular machinery of macroautophagy</article-title>. <source>Cell. Microbiol.</source>
<volume>16</volume>, <fpage>1627</fpage>&#x02013;<lpage>1636</lpage>. <pub-id pub-id-type="doi">10.1111/cmi.12358</pub-id><?supplied-pmid 25244600?><pub-id pub-id-type="pmid">25244600</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>I.</given-names></name><name><surname>Amano</surname><given-names>A.</given-names></name><name><surname>Mizushima</surname><given-names>N.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Kamimoto</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Autophagy defends cells against invading group A Streptococcus</article-title>. <source>Science</source>
<volume>306</volume>, <fpage>1037</fpage>&#x02013;<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1126/science.1103966</pub-id><?supplied-pmid 15528445?><pub-id pub-id-type="pmid">15528445</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>M.</given-names></name><name><surname>Sasakawa</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Shigella and autophagy</article-title>. <source>Autophagy</source>
<volume>2</volume>, <fpage>171</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.4161/auto.2829</pub-id><?supplied-pmid 16874102?><pub-id pub-id-type="pmid">16874102</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>S. J.</given-names></name><name><surname>Batzloff</surname><given-names>M.</given-names></name><name><surname>Chehrehasa</surname><given-names>F.</given-names></name><name><surname>Meedeniya</surname><given-names>A.</given-names></name><name><surname>Casart</surname><given-names>Y.</given-names></name><name><surname>Logue</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis</article-title>. <source>J. Infect. Dis.</source>
<volume>199</volume>, <fpage>1761</fpage>&#x02013;<lpage>1770</lpage>. <pub-id pub-id-type="doi">10.1086/599210</pub-id><?supplied-pmid 19456230?><pub-id pub-id-type="pmid">19456230</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pareja</surname><given-names>M. E.</given-names></name><name><surname>Colombo</surname><given-names>M. I.</given-names></name></person-group> (<year>2013</year>). <article-title>Autophagic clearance of bacterial pathogens: molecular recognition of intracellular microorganisms</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>3</volume>:<fpage>54</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2013.00054</pub-id><?supplied-pmid 24137567?><pub-id pub-id-type="pmid">24137567</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prudencio</surname><given-names>M.</given-names></name><name><surname>Rodrigues</surname><given-names>C.</given-names></name><name><surname>Hannus</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><name><surname>Real</surname><given-names>E.</given-names></name><name><surname>Goncalves</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Kinome-wide RNAi screen implicates at least 5 hepatocyte kinases in <italic>Plasmodium</italic> sporozoite infection</article-title>. <source>PLoS Pathog</source>. <volume>4</volume>:<fpage>e1000201</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000201</pub-id><?supplied-pmid 18989463?><pub-id pub-id-type="pmid">18989463</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>P. H.</given-names></name><name><surname>Belanger</surname><given-names>M.</given-names></name><name><surname>Dunn</surname><given-names>W.</given-names><suffix>Jr.</suffix></name><name><surname>Progulske-Fox</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title><italic>Porphyromonas gingivalis</italic> and the autophagic pathway: an innate immune interaction?</article-title>
<source>Front. Biosci.</source>
<volume>13</volume>, <fpage>178</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.2741/2668</pub-id><?supplied-pmid 17981536?><pub-id pub-id-type="pmid">17981536</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romao</surname><given-names>S.</given-names></name><name><surname>Gannage</surname><given-names>M.</given-names></name><name><surname>Munz</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Checking the garbage bin for problems in the house, or how autophagy assists in antigen presentation to the immune system</article-title>. <source>Semin. Cancer Biol.</source>
<volume>23</volume>, <fpage>391</fpage>&#x02013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2013.03.001</pub-id><?supplied-pmid 23541679?><pub-id pub-id-type="pmid">23541679</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouleux-Bonnin</surname><given-names>F.</given-names></name><name><surname>Monsigny</surname><given-names>M.</given-names></name><name><surname>Legrand</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>Transcriptional expression of mannose receptor gene during differentiation of human macrophages</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>217</volume>, <fpage>106</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1995.2751</pub-id><?supplied-pmid 8526897?><pub-id pub-id-type="pmid">8526897</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweizer</surname><given-names>H. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanisms of antibiotic resistance in <italic>Burkholderia pseudomallei</italic>: implications for treatment of melioidosis</article-title>. <source>Future Microbiol.</source>
<volume>7</volume>, <fpage>1389</fpage>&#x02013;<lpage>1399</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.12.116</pub-id><?supplied-pmid 23231488?><pub-id pub-id-type="pmid">23231488</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>B. M.</given-names></name><name><surname>Chantratita</surname><given-names>N.</given-names></name><name><surname>Ooi</surname><given-names>W. F.</given-names></name><name><surname>Nandi</surname><given-names>T.</given-names></name><name><surname>Tewhey</surname><given-names>R.</given-names></name><name><surname>Tan</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates</article-title>. <source>Genome Biol.</source>
<volume>11</volume>:<fpage>R89</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2010-11-8-r89</pub-id><?supplied-pmid 20799932?><pub-id pub-id-type="pmid">20799932</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>L. D.</given-names></name><name><surname>Vargaftig</surname><given-names>B. B.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Gruber</surname><given-names>A. D.</given-names></name><name><surname>Adler</surname><given-names>K. B.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma</article-title>. <source>Nat. Med.</source>
<volume>10</volume>, <fpage>193</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1038/nm983</pub-id><?supplied-pmid 14716307?><pub-id pub-id-type="pmid">14716307</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soh</surname><given-names>J. W.</given-names></name><name><surname>Weinstein</surname><given-names>I. B.</given-names></name></person-group> (<year>2003</year>). <article-title>Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>34709</fpage>&#x02013;<lpage>34716</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M302016200</pub-id><?supplied-pmid 12794082?><pub-id pub-id-type="pmid">12794082</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>M. P.</given-names></name><name><surname>Friebel</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>L. A.</given-names></name><name><surname>Wood</surname><given-names>M. W.</given-names></name><name><surname>Brown</surname><given-names>P. J.</given-names></name><name><surname>Galyov</surname><given-names>E. E.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>A <italic>Burkholderia pseudomallei</italic> type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity</article-title>. <source>J. Bacteriol.</source>
<volume>185</volume>, <fpage>4992</fpage>&#x02013;<lpage>4996</lpage>. <pub-id pub-id-type="doi">10.1128/JB.185.16.4992-4996.2003</pub-id><?supplied-pmid 12897019?><pub-id pub-id-type="pmid">12897019</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudan</surname><given-names>R.</given-names></name><name><surname>Srivastava</surname><given-names>N.</given-names></name><name><surname>Pandey</surname><given-names>S.</given-names></name><name><surname>Majumdar</surname><given-names>S.</given-names></name><name><surname>Saha</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Reciprocal regulation of protein kinase C isoforms resuls in differential cellular responsiveness</article-title>. <source>J. Immunol.</source>
<volume>188</volume>, <fpage>2328</fpage>&#x02013;<lpage>2337</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1101678</pub-id><?supplied-pmid 22271653?><pub-id pub-id-type="pmid">22271653</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suparak</surname><given-names>S.</given-names></name><name><surname>Kespichayawattana</surname><given-names>W.</given-names></name><name><surname>Haque</surname><given-names>A.</given-names></name><name><surname>Easton</surname><given-names>A.</given-names></name><name><surname>Damnin</surname><given-names>S.</given-names></name><name><surname>Lertmemongkolchai</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Multinucleated giant cell formation and apoptosis in infected host cells is mediated by <italic>Burkholderia pseudomallei</italic> type III secretion protein BipB</article-title>. <source>J. Bacteriol.</source>
<volume>187</volume>, <fpage>6556</fpage>&#x02013;<lpage>6560</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.18.6556-6560.2005</pub-id><?supplied-pmid 16159789?><pub-id pub-id-type="pmid">16159789</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulett</surname><given-names>G.</given-names></name><name><surname>Labrooy</surname><given-names>J.</given-names></name><name><surname>Currie</surname><given-names>B.</given-names></name><name><surname>Barmes</surname><given-names>J.</given-names></name><name><surname>Ketheesan</surname><given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>A model of immunity to <italic>Burkholderia pseudomallei</italic>: unique responses following immunization and acute lethal infection</article-title>. <source>Microb. Infect.</source>
<volume>7</volume>, <fpage>1263</fpage>&#x02013;<lpage>1275</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2005.04.013</pub-id><?supplied-pmid 16027024?><pub-id pub-id-type="pmid">16027024</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underhill</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Allen</surname><given-names>L.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>MacMARCKS is not essential for phagocytosis in macrophages</article-title>. <source>J. Biol. Chem.</source>
<volume>273</volume>, <fpage>33619</fpage>&#x02013;<lpage>33623</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.50.33619</pub-id><pub-id pub-id-type="pmid">9837946</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underhill</surname><given-names>D.</given-names></name><name><surname>Ozinsky</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Phagocytosis of microbes: complexity in action</article-title>. <source>Ann. Rev. Immunol.</source>
<volume>20</volume>, <fpage>825</fpage>&#x02013;<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.20.103001.114744</pub-id><?supplied-pmid 11861619?><pub-id pub-id-type="pmid">11861619</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eis</surname><given-names>M.</given-names></name><name><surname>Evenou</surname><given-names>J.</given-names></name><name><surname>Floersheim</surname><given-names>P.</given-names></name><name><surname>Gaul</surname><given-names>C.</given-names></name><name><surname>Cowan-Jacob</surname><given-names>S.</given-names></name><name><surname>Monovich</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>2,6-naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>21</volume>, <fpage>7367</fpage>&#x02013;<lpage>7372</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2011.10.025</pub-id><?supplied-pmid 22078216?><pub-id pub-id-type="pmid">22078216</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiersinga</surname><given-names>W. J.</given-names></name><name><surname>van der Poll</surname><given-names>T.</given-names></name><name><surname>White</surname><given-names>N. J.</given-names></name><name><surname>Day</surname><given-names>N. P.</given-names></name><name><surname>Peacock</surname><given-names>S. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Melioidosis: insights into the pathogenicity of <italic>Burkholderia pseudomallei</italic></article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>4</volume>, <fpage>272</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1385</pub-id><?supplied-pmid 16541135?><pub-id pub-id-type="pmid">16541135</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wollenberg</surname><given-names>A.</given-names></name><name><surname>Mommaas</surname><given-names>M.</given-names></name><name><surname>Oppel</surname><given-names>T.</given-names></name><name><surname>Schottdorf</surname><given-names>E. M.</given-names></name><name><surname>Gunther</surname><given-names>S.</given-names></name><name><surname>Moderer</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases</article-title>. <source>J. Invest. Dermatol.</source>
<volume>118</volume>, <fpage>327</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01665.x</pub-id><?supplied-pmid 11841552?><pub-id pub-id-type="pmid">11841552</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongprompitak</surname><given-names>P.</given-names></name><name><surname>Sirisinha</surname><given-names>S.</given-names></name><name><surname>Chaiyaroj</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Differential expression profiles of lung epithelial cells exposed to <italic>Burkholderia pseudomallei</italic> and <italic>Burkholderia thailandensis</italic> during the initial phase of infection</article-title>. <source>Asian Pac. J. Allergy Immunol.</source>
<volume>27</volume>, <fpage>59</fpage>&#x02013;<lpage>70</lpage>. <?supplied-pmid 19548631?><pub-id pub-id-type="pmid">19548631</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Shiraishi</surname><given-names>M.</given-names></name><name><surname>Fukami</surname><given-names>K.</given-names></name><name><surname>Tanabe</surname><given-names>A.</given-names></name><name><surname>Ikeda-Matsuo</surname><given-names>Y.</given-names></name><name><surname>Naito</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>MARCKS regulates lamellipodia formation induced by IGF-I via association with PIP2 and beta-actin at membrane microdomains</article-title>. <source>J. Cell. Physiol.</source>
<volume>220</volume>, <fpage>748</fpage>&#x02013;<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21822</pub-id><?supplied-pmid 19475567?><pub-id pub-id-type="pmid">19475567</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zauberman</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>S.</given-names></name><name><surname>Mamroud</surname><given-names>E.</given-names></name><name><surname>Flashner</surname><given-names>Y.</given-names></name><name><surname>Tidhar</surname><given-names>A.</given-names></name><name><surname>Ber</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Interaction of <italic>Yersinia pestis</italic> with macrophages: limitations in YopJ-dependent apoptosis</article-title>. <source>Infect. Immun.</source>
<volume>74</volume>, <fpage>3239</fpage>&#x02013;<lpage>3250</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00097-06</pub-id><?supplied-pmid 16714551?><pub-id pub-id-type="pmid">16714551</pub-id></mixed-citation></ref></ref-list></back></article>